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ABSTRACT
Maintenance of cancer stem cells (CSCs) is regulated by their microenvironment. As
cancer cells are affected by many factors in their microenvironment, a major challenge is
to isolate the effect of a specific factor on CSCs while keeping other factors unchanged.
We developed a synthetic inert 3D Poly Ethylene Glycol Di-Acrylate (PEGDA) gel
culture system as a unique tool to study the effect of microenvironmental factors on CSCs
response. Synthetic hydrogels provide the flexibility to design three-dimensional (3D)
matrices to isolate and study individual factors in the tumor microenvironment.
The first objective of this work was to investigate the effect of physical properties of
microenvironment including modulus and geometry on maintenance of CSCs isolated of
4T1 (mouse breast cancer cell line), MCF7 and MDA-MB-231 (human Breast carcinoma
cells) HCT116 (Colon), AGS (Gastric) and U-2 OS (Bone) human cancer cell lines in an
inert microenvironment. We have shown that the gel elastic modulus had a strong effect
on tumorsphere formation. CSCs formed in the inert PEGDA gel keep their stemness
within certain ranges of gel stiffness. Briefly, mouse and human breast cancer cells
encapsulated in the gel with approximate modulus of 5 kPa formed the largest and
highest density of tumorspheres with highest expression of breast CSC markers.The
highest number, diameter and CSC marker expression of HCT116 and AGS spheroids
were observed in 25 kPa where it occurred at an optimum modulus of 50 kPa for U-2 OS
cell line.
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We have also shown that geometry and spatial properties of ECM can significantly affect
the proliferation rate and size of tumorspheres formed by MDA-MB-231 cells in PEGDA
micropatternedhydrogesl. Weintroduced a 3D culture system as a model that controls the
uniformity, size and proliferation of tumorspheres.
As thesecondary objective,we investigated the effect of ECM composition on CSCs
maintenance by using ECM-derived cell binding peptides active in malignancy. CD44
binding peptide (CD44bp), Integrin binding peptides (Ibps) and Heparin binding peptides
(Hbps) were conjugated to the gel or dissolved in polymer solution to study their effect
on the maintenance of CSCs.
We have shown that peptides derived from ECM proteins with different mechanisms of
action can influence the microenvironment and cancer cells functions by either promotion
or abolition of the spheroid forming ability in the inert 3D PEGDA hydrogel cell culture
system. Conjugation of CD44bp and Ibps to the gel inhibited tumorsphere formation in
vitro and in vivo where Hbps enhanced tumorsphere formation and CSCs marker
expression compared to cells in the gel without peptide.
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CHAPTER 1
INTRODUCTION
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1.1 BACKGROUND
Cancer is one of the main causes of death worldwide[1]. Itdevelops with
uncontrollablecell growth in a process, which may take several years. This process can
originate from any damage or mutation in genes.
Tumors are heterogeneous in their nature. It means that cells population in different
levels of differentiation and invasiveness coexists together.The resistance of high grade
tumors with none or poorly differentiated cancer cells to conventional cancer therapies
such as chemotherapy is the major challenge in cancer treatment. Cells in the high grade
tumors look abnormal, spread quickly and have high potential to relapse. Cancer stem
cells (CSCs) theory relates the aggression of high grade tumors to the high fraction of
CSCs with the ability of self-renewal and differentiation to all cell types in a tumor i.e.,
the triple negative breast cancer, one of the most aggressive types of breast cancer,
contains a high fraction of CSCs [2-4].
Cancer stem cells model relates this heterogeneity to the existence of Cancer Stem Cells
(CSCs) with the ability to give rise to all cell types in a tumor tissue and regenerating it.
Therefore, it is necessary to know the properties and mechanisms of action in CSCs to
find new ways in cancer treatment and prevention.
1.2 CANCER STEM CELLSMODEL
The body’s continuous cell turnover and tissue repair system is related to stem cells, a
small population of undifferentiated cells with unique potential of
1) Differentiation: the ability to give rise to different short-lived mature cell types of
a tissue with the specialized functions.
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2) Self-renewal: the ability to proliferate and make copies of themselves for long
periods of time
3) Homeostatic control: the ability to make a balance between differentiation and
self-renewal based on micro environmental stimuli and cues.
Stem cells categorizes in different groups based on their potential of differentiation. It
ranges from totipotent stem cells havingthe ability of differentiation to any cell type in an
organism to unipotent stem cells with the ability to differentiate to one cells type. Adult
Stem Cells have mostly defined as multipotent cells.They are able todevelop all cell types
of a specific organ. Stem cells can stay dormant and inactive for a long period. They start
their activity and division under certain physiological conditions. The fate of daughter
cells through cell division is strongly dependent on the microenvironmental signals and
cues. Daughter cells can keep their stemness properties and remain unspecialized or can
differentiate to specific cells with defined functions[5].
There is a specific microenvironment for stem cells of different tissues.This
microenvironment called stem cells niche consisting of neighboring cells and their
extracellular matrices helps stem cells to optimize their function and keep their unique
potential of self-renewal and differentiation. Various factors such as signals from proteins
and cytokines in extracellular matrix or physical interaction to surrounding stromal cells
cooperate to keep stem cells niche highly organized and inhibit the differentiation of stem
cells. Consequently, detachment of stem cells of their niche can cause stem cell to lose
their extraordinary potential. Outside their niche, they need sufficient intrinsic factors to
keep their stemness properties and avoid differentiation. Cancer can result from multiple
step process of genetic mutation in a single target cell over a long period and stem cells,
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as the long-lived cells in many tissues can be good target for this transforming mutation.
Like normal tissues, tumors are composed of heterogeneous populations of cells in
different levels of differentiation.
Cancer cells in a tumor can be divided to different groups according to the expression of
specific surface markers. Being injected to appropriate host such as immune-deficient
mouse, tumorigenic capacity of each subset will be compared. Based on CSC model, only
a minority of cancer cells with specific surface markers (CSC subset) is able to form
tumors, whereas the majority of differentiated cells should not. Irrespective of the origin
of CSCs, they provide a hierarchical system with the unique potential to self-renew and
maintain tumor heterogeneity by giving rise to all different cell types of tumor. This
heterogeneity comes from the cancer stem cells ability of dividingasymmetrically and
giving rise to daughter cells which keepstemness properties of parental stem cellas well
as progenitor cells that lacks self-renewal property and have a tendency to differentiate to
other non-tumorigenic cancer cells forming the bulk of the tumor.
CSCs model has been verified in different tumor systems including breast and brain solid
tumors. The results showed that, in human breast cancers, only a small subsetof tumor
cells, defined as [CD44+ CD24−/low] comprising 11%–35% of total cancer cells has the
tumorigenicpotential to regenerate the whole tumor. In brain tumors, the stem cells
properties has been successfully applied to the specific subset of CD133+ cells which
usually include 5%–30% of total tumor cells. As expected this subset of CD133+ cells
was able to form the whole tumor tissue after injection [5]. It is not easy to isolate the
cancer stem cells in tumors. Recent progress in this way has introduced some new
methods for this isolation that are similar with the strategies used to identify and enrich
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normal stem cells. Implanting cells in immunedeficient mice at different cell doses can
assess the level of tumorigenicity of these isolated CSCs. Tumor initiating cells are
supposed to be able to develop tumors in low densities.
This hypothesis that cancer recurrence is related to the existence of cancer stem cells
(CSCs) with the ability of differentiation into multiple cell types and resistance to
conventional therapies comparing bulk tumor cells caused much effort to explore better
ways of treatment based on this subpopulation of tumor tissues.Although conventional
therapies such as chemotherapy or radiotherapy can kill differentiated,cancer cells but
they are not able to eradicate CSCs population. CSCs are slow in cell division and this
helps their resistance to chemotherapeutic drugs, which are more effective on rapidly
replicating differentiated cancer cells. They are also provided with some transmembrane
proteins such as ATP-binding cassette (ABC) transporters family known as drug
resistance proteins with the ability of pumping out the chemotherapeutic drugs and DNA
repairing agents. CSCs survive conventional therapies and cause relapse of tumor.
In regard of CSCs theory, tumor eradication will need specific agents to target CSCs
selectively without killing normal stem cells of the body. These agents and other similar
ways like enforcing CSCs to be differentiated to progenitor cells with more restricted
properties will ultimately result in CSCs elimination and tumor regression as well as
metastasis prevention. Some studies have focused on the possibility of identifying
specific markers that distinguish CSCs from the bulk of the tumor and normal stem cells
as well as specific agents that are able to discriminate between these markers and other
ones.One of these agents are inhibitory peptides which are short proteins used in clinical
research to examine their effects on CSCs. This method is highly selective, less toxic in
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comparison with novel developed toxic drugs and more efficient among different
methods of cancer therapy. Although peptides in comparison with proteins are more
specific, stable and bio-available in their nature, identifying effective peptide sequence
that can specifically target CSCs or induce their differentiation is still a main issue.
Among Bioactive peptides, only a few are therapeutically useful and show moderate
efficacy in cancer treatment. Using these peptides with conventional drugs reduce their
toxicity level and make them more selective for killing CSCs.
Direct interaction and inhibitory effect of some peptides on protein markers has drawn
more attention to knowing and isolating specific markers of CSCs in cancer research
including CD133, CD90, CD44, CD24, ABCG2, SCA1 and ALDH. Although these
markers are not exclusively expressed in cancer stem cells, but can be useful for isolation
the enriched subset of CSCs as a base for further studies including self-renewal assays.
CD44, a cell-surface glycoprotein has been recognized as one of the main markers to
identify CSCs in several tumor tissues i.e., CD44 positive CSC-like cells showed
enhanced ability for metastasis in different tumor cells [6-8]. For instance, this protein
has been widely expressed in breast cancer tumors that is used to enrich cells population
with stem-like characteristics [9, 10]. This marker binds to various ECM ligands mainly
HA and collagen to regulate many signaling pathways related to tumor invasion,
metastasis and growth [11, 12]. Extensive studies used the anti-CD44 antibodies as a
therapeutic agent to target CD44 [13-15].Therefore, identifying specific agents to target
CD44 is potentially a promising method for tumor suppression, especially in CD44
overexpressed tumors. Recently it has been reported that the laminin alpha5 synthetic
peptide A5G27 (RLVSYNGIIFFLK, residues 2,892-2,904), a CD44 binding peptide
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inhibits tumor cell migration, invasion, and angiogenesis of B16-F10 melanoma cells in a
dominant-negative manner and inhibits Cancer stem cells microenvironment [16].
CSCs with theproperties ofnormal stem cellsuse similar signaling pathways to maintain
their stemness. However, they may respond to the environmental cue differently. Under
normal conditions, stem cells keep the balance between proliferation and differentiation
but CSCs, due to mutations in the cell, are self-sufficient and involve unregulated cell
proliferation[17, 18]. It has been proposed that the stem cell niche is converted from
proliferation inhibitory to signals favoring cell proliferation in the case of CSCs. For
instance, the tumor stromais characterized by extracellular matrix (ECM) remodeling and
stiffening. The limited knowledge of the relation between ECM stiffening and tumor
progression has brought many questions into this field of study [19].
Two major factors make it difficult to study tumor microenvironment in vivo. First,
animal models may not adequately reproduce the features of human cancers in vivo. The
process of cancer development may take many years and immune-compromised animals
frequently used to study molecular pathways or drug response, in most cases cannot
provide a complete model for human tumor because of their short life span. Second, it is
difficult to study the effect of a specific factor in the microenvironment while keeping all
other factors unchanged. Therefore, there is a need to develop in vitro models to study the
molecular basis of tumorigenesis and progression.
Most in vitro studies use standard two-dimensional (2D) cell culture. However, cells
grown on 2D tissue culture lack proper cell–cell and cell–matrix interactions and behave
differently from those grown in 3D environment.Removing cells from their natural
tissues and culturing them in conventional culture systems such as 2D culture plates
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changes all aspects of cell behavior from morphology to gene expression and
differentiation pattern [20, 21]. For example, it has been reported that culturing human
breast carcinoma cells on flat 2D culture plates changed their proliferation and
differentiation pattern and reduced their malignancy compared with those under in vivo
conditions [22]. Thus, developing 3D culture systems in which cells sustain their tissue
specific phenotype is critical. This helps cancer researchers to understand the
mechanisms by which CSCs maintain and progress.Most 3D models promote cell–cell
interaction, adhesion, migration, and in vivo–like morphogenesis.
Among existing in vitro culture methods, growing tumorspheres in suspension on ultralow-attachment plates is a commonly used traditional method to enrich CSCs in vitro but
cannot mimic the tissue specific chemical and mechanical properties of ECM for cells.
Various types of materials have been used to generate a 3D matrix. naturally-derived 3D
matrices used for immobilization of CSCs in vitro reduced difficulties of following
progression of these cells in vivo but still do not allow studying the effect of
environmental factors individually, due to their many ligand-receptor interactions. Type
1 collagen and Matrigel are the most widely used matrices [23] because they are
biocompatible and support adhesion and growth of many cell types [24, 25]. Alginate and
agarose gels are also used as a matrix to study the behavior of breast cancer cells under a
3D condition [26, 27].Several studies have used natural hydrogels to study the effect of
microenvironmental factors on cancer cells fate [28-31]. However, it is difficult to isolate
and study cell response to individual factors in the microenvironment with naturally
derived matrices that have many interactions with cell surface receptors [32]. Compared
to natural hydrogels, the synthetic hydrogels with defined structure can be a good choice
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to study the independent effect of ECM factors in vitro. These matrices allow precise
control of different factors such as conjugated bioactive peptides on CSCs behavior and
differentiation followed by studying targeted cancer therapy using antibodies or bioactive
peptides to bind to specific markers on the surface of tumor stem cells. . Among them,
polyethylene glycol (PEG) hydrogel has been extensively used as an engineered matrix
for cell encapsulation to elucidate the effect of factors in the microenvironment on cell
fate [33-36].
Recent advances in cancer research have highlighted the importance of CSCs interaction
with the microenvironment at cellular and molecular levels [37]. The maintenance of
CSCs is highly dependent on their interactions with ECM and surrounding cells i.e.,
proper intercellular interaction plays a critical role in cancer pathogenesis [38]. Epithelial
cells interact with surrounding cells through different mechanisms of adherens, gap and
tight junctions. Making changes in the pattern of interactions between adjacent cells may
affect the phenotype and functionality of cancer cells [39]. Growing evidence show that
major signaling pathways involved in maintenance of both normal and cancer stem cells
including Notch, Wnt and Hedgehog depend on the level of interactions with their
adjacent cells [40].
Several studies suggest that the role of ECM in self-renewal and differentiation of stem
cells is not limited to the matrix mediated chemical cues but the role of physical signaling
in cancer progression and stem cells functionality is indisputable [41-45]. ECM stiffness
will increase tension and change cells properties in regard of growth, survival, migration
and morphogenesis. Reducing this tension, malignant behavior of cancer cells will be
repressed. Geometrical condition of ECM can also affect the way cells reach nutrients
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and growth factors which plays critical roles in cancer initiation, progression, and
metastasis [20]. Cells sense and respond to geometry of the microenvironment in various
levels. For example they respond the morphology of ECM and arrangement of
neighboring cells in microscale [46, 47].
In vivo, the stiffness of cells microenvironment is highly variable ranging from softer
(breast, gastric) to hard (bone, teeth) tissues. Cells have the ability to sense and respond
to matrix stiffness by synthesizing the appropriate extracellular matrix (ECM)
composition as the mechanical properties and composition of hard and soft tissues differ
significantly. In 3D culture systems, elastic modulus of the matrix can direct
differentiation of encapsulated stem cells and shift the balance of cell proliferation and
apoptosis [48-50]. Likewise, the proliferation, differentiation, migration, and apoptosis of
cancerous cells in the tumor tissue are regulated by matrix stiffness [38, 51, 52].
Therefore, cells need to respond appropriately to the environmental cues for survival [53]
and it is important to provide the appropriate range of stiffness in the local
microenvironment for cells to survive [54, 55].
Recent advances in studying the mechanical properties of ECM allow researchers to
investigate the higher aspects of ECM biomechanics and their key role in stem cells fate.
For example, microfabrication techniques have been recently used to control the size of
spheroids in substrates through the physical confinement of the micropatterned wells [5658]. Several studies have focused the effect of microenvironmental factors on the
maintenance of normal stem cells [59-61]. However, the individual role of mechanical
and chemical properties of ECM on CSCs in an inert matrix has not been investigated. In
this study, primarily we investigated the effect of cancer cells density on tumorsphere
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formation using MDA-MB-231 encapsulated in the 5kPa PEGDA hydrogel. We show
that tumorsphere formation is highly dependent on the number density of encapsulated
cells and happens in a certain range of density. This study continued with the effect of
matrix elastic modulus on the formation, growth, and maintenance of CSCs using 4T1,
MCF7, MDA-MB-231 breast cancer cell lines with different level of malignancies,
HCT116, AGSand U-2 OS cancer cell lines encapsulated in a range of moduli of PEG
hydrogels, in the absence of attached ligands that interact with cell surface receptors.
MCF10a, a normal human breast epithelial cell line was used as control to be compared
with the cancer cell lines by their sphere formation ability. We showed that the formation
and maintenance of tumorspheroids in these cancer cell lines are modulated by the elastic
modulus of the PEG matrix.
For the purpose of comparison, we used the layer-by-layer micropatterning technique to
employ pre-defined zones of cell encapsulation in PEGDA hydrogels and control the size
of formed spheroids. We compared the CSCs properties of formed tumorspheroids in
micropatterns with the control group of non-patterned hydrogels and indicate that the
spatial limitation of micropatterns may control the size of formed spheroids and maintain
the CSCs properties.
Following the study ofmechanical properties, the inert PEGDA hydrogel, in certain range
of moduli, was used as a 3D cell culture model to investigate the role of cell binding
peptides in the maintenance of CSCs. More specifically, we investigated the effect of
A5G27 peptide on CD44 overexpressed breast, colon and bone CSCs. We also studied
the effect of additional ECM-derived cell binding peptides that are active in malignancy
on the maintenance of CSCs.
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We chose two peptides of fibronectin, the major components of ECM mediating
tumorigenicity, a well-known integrin binding RGD peptide (I1) and FC/HV a
fibronectin-derived heparin-binding peptide (H1). It has been shown in several studies
that laminin-111, one of 15 isoforms of laminin, plays a major role in tumor cells
adhesion, migration, growth and metastasis [62, 63]. We chose YIGSR (I3), a wellstudied laminin-derived active peptide located on the β l chain, and IKVAV (I2) another
peptide sequence on α chain of laminin-111 to study their effect on CSCs maintenance.
Col IV is the other structural protein that plays an important role in tumor progression
[64, 65]. In this study, we investigated the effect of two different heparin binding
peptides derived from Collagen IV, Hep I (H2) and Hep III (H3) on the tumorspheroid
formation and CSCs maintenance.
1.3 HYPOTHESIS
1.3.1 PEG based hydrogels with a wide range of mechanical properties and water
content as an inert engineered 3D matrix can provides a novel tool to control and
investigate the effect of microenvironmental factors on maintenance of CSCs in vitro.
1.3.2 Culturing cancer cells in confined areas of PEGDAmicropatterns may provide a
useful 3D in vitro culture system to mimic the spatial limitations of CSCs
microenvironment and controlsthe proliferation and size of tumorspheres.
1.3.3 CD44, Integrin and heparin binding peptides conjugated to the gel can affect the
maintenance of CSCs encapsulated in PEGDA hydrogel culture system.
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CHAPTER 2
MATERIALS AND METHODS
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2.1 MACROMER SYNTHESIS AND CHARACTERIZATION
The PEG macromer was functionalized with acrylate groups to produce PEGDA by the
reaction of acryloyl chloride with hydroxyl end-groups of PEG. TEA was used as the
reaction catalyst. Prior to the reaction, PEG was dried by azeotropic distillation from
toluene to remove residual moisture. The polymer was dissolved in dried DCM in a
reaction flask and the flask was immersed in an ice bath to cool the solution. In a typical
reaction, 5.6 ml acryloyl chloride and 9.7 ml TEA, each dissolved in DCM, were added
drop-wise to the reaction with stirring. The reaction was allowed to proceed for 12 h
under nitrogen flow. After completion of the reaction, the solvent was removed by rotary
evaporation and the residue was dissolved in anhydrous ethyl acetate to precipitate the
by-product triethylamine hydrochloride salt. Next, ethyl acetate was removed by vacuum
distillation; the macromer was re-dissolved in DCM and precipitated twice in cold ethyl
ether. Then, the macromer was dissolved in Dimethyl sulfoxide (DMSO) and dialyzed
against distilled deionized (DI) water to remove the by-products. The PEGDA product
was freeze-dried and stored at -20ºC. A hydrolytically degradable version of the PEGDA
gel (dPEGDA) was synthesized with a similar procedure as described previously[36].
The chemical structure of the functionalized macromer was characterized by a Varian
Mercury-300 1H-NMR (Varian, Palo Alto, CA) at ambient conditions with a resolution
of 0.17 Hz. The sample was dissolved in deuterated chloroform at a concentration of 5
mg/ml and 1% v/v TMS was used as the internal standard.
2.2 HYDROGEL SYNTHESIS AND MEASUREMENT OF GEL MODULUS
The PEGDA macromerswere cross-linked in aqueous solution by ultraviolet (UV)initiated radical polymerization with 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl)
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ketone (Irgacure 2959; CIBA, Tarrytown, NY) photoinitiator. 10 milligrams of initiator
were dissolved in 1mL PBS by vortexing and heating to 50°C. To prepare 2, 5, 25, 50,
and 70 kPa moduli ofPEGDA hydrogel precursor solutions, 5, 10, 15, 20, and 25 wt%of
PEGDA macromer were dissolvedinthe initiator solution, respectively. The hydrogel
precursor solutionswere degassed and transferred to a polytetrafluoroethylene (PTFE)
mold (5 cm × 3 cm× 750 m), covered with a transparent glass plate, fastened with clips,
and UV irradiated with a BLAK-RAY 100W mercury, long-wavelength (365 nm) UV
lamp (Model B100-AP; UVP, Upland,CA) for 10 min. Disk-shaped samples were cut
from the gel using an 8-mm cork borer and swollen in PBS for 24 h at 37°C. To measure
the elastic modulus of gels, samples were loaded on the Peltier plate of the rheometer
(TA Instruments, New Castle, DE) and subjected to a uniaxial compressive force at a
displacement rate of 7.5 mm/s. The slope of the linear fit to the stress–strain curve for
5%–10% strain wastaken as the elastic modulus (E) of the gels.
2.3 CSC CULTURE AND CHARACTERIZATION
4T1, MDA-MB-231, MCF7, HCT116 and AGS tumor cell lines were cultured in RMPI1640 medium supplemented with 10% FBS. U-2 OS cells were grown in DMEM
medium with 10% FBS where MCF10a were cultured in DMEM-F12 supplemented with
0.5 mg/ml Hydrocortisone, 10 μg/ml insulin, 100 ng/ml Cholera toxin, 20 ng/ml EGF
and, 5% horse serum. Cells were trypsinized after reaching 70% confluency. PEGDA
macromer was dissolved in PBS and sterilized by a 0.2 m filter. Next, 5 ×105/ml cells
were added to the macromer solution with final PEGDA concentrations ranging 2–70kPa
and mixed gently with a pre-sterilized glass rod. The cell-suspended hydrogel precursor
solution was cross-linked with UV for approximately 10 minutes. After crosslinking, the
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gel was cut into disks and incubated in stem cell culture medium under 5% CO2. The
stem cell medium consisted of DMEM-F12 supplemented with 0.4% BSA, 5 mg/mL
insulin, 40 ng/mL bFGF, 20 ng/mL EGF, 5% horse serum, 100U/mL penicillin, and 100
mg/mL streptomycin [66]. For growing tumorspheres in suspension, trypsinized 4T1 cells
were cultured on ultra-low-attachment tissue culture plates with stem cell culture medium
under 5% CO2 at 37°C as described previously [66-68]. The gold standard for
characterization of CSC tumorspheres for stemness is by the ability to form tumor in
vivo[69, 70]. To test for tumor formation, a stable 4T1 cell line that expressed luciferase
(4T1-Luc)was established as described. Luciferase expression vector

pGL4.50

[Luc2/CMV/Hygro] (Promega, Madison, WI) was transfected into 4T1 cells by
Lipofectamine 2000 (Invitrogen), according to the manufacturer’s instructions, to
generate a cell line expressing luciferase as a reporter [71]. After 24 h, cells were
trypsinized and cultured in RPMI-1640 medium with 400 mg/mL of hygromycin for 3
weeks to generate 4T1-Luc cells. 4T1-Luc cells were cultured on adhesion plates
withregular RPMI-1640 culture medium or on ultra-low-attachment plates with stem cell
culture medium as described previously.After one week, cells were trypsinized and
counted. Different number of cells (5000 and 50,000 cells from adhesion plates or 500,
1000, and 5000 tumorsphere cells from ultra-lowattachment plates) was injected
subcutaneously in syngeneic Balb/c mice (6 mice/group). One week after inoculation,
100 mL of D-Luciferin (30mg/mL; Caliper, Hopkinton, MA) was injected
subcutaneously and mice were imaged 10 minafter Luciferin injection by Caliper’s IVIS
Spectrum imaging system (Caliper Life Sciences, Hopkinton, MA).
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2.4 CELL IMAGING AND DETERMINATION OF CELL NUMBER
To determine cell viability, gels were stained with cAM/EthD live/dead dyes 2 days after
encapsulation to image liveand dead cells, respectively. Stained samples were
imagedwith an inverted fluorescent microscope (Nikon Eclipse Ti-e;Nikon, Melville,
NY). Cell viability was quantified by dividingthe image into smaller squares and
counting the number of live and dead cells. At each time point, the gel samples were
removed from the culture media and stained for imaging. Samples were rinsed twice with
PBS and fixed with 4% paraformaldehyde for 3h. After fixation, cells were permeabilized
using PBS containing 0.1% Triton X-100 for 5min. After rinsing, cells were incubated
with Alexa 488 phalloidin (1:200 dilution) and DAPI (1:5000 dilution) to stain actin
filaments of the cell cytoskeleton and cell nuclei, respectively.
Stained samples were imaged with a Nikon Eclipse Ti-e inverted fluorescent microscope.
For visualization of cell uniformity, a confocal fluorescent microscope (Zeiss LSM510META Axiovert; Carl Zeiss, Germany) was used to obtain 2D images (90-mm-thick
layers) of the stained gels in the direction of thickness, as described [72]. For
determination of cell number the gel samples were homogenized, cells were lysed, and
aliquots were used to measure the dsDNA content using a Quant-it PicoGreen assay as
described[73]. Briefly, an aliquot (100 L) of the working solution was added to 100 L
of thecell lysate and incubated for 4 min at ambient conditions. The fluorescence of the
solution was measured with a plate reader (Synergy HT; Bio-Tek, Winooski, VT) at
emission

and

excitation

wavelengths

of

485

and

528nm,

respectively.

Measuredfluorescent intensities were correlated to cell numbers using a calibration curve
constructed with cells of known concentration ranging from zero to 106 cells/mL.
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2.5 BRDU RETENTION ASSAY AND IMMUNOFLUORESCENT IMAGING
BrdU label retention was used to identify mammary CSCs as described [74, 75].
Nonconfluent 4T1 cells were incubated with 10 mM of BrdU for 10 days to label the
DNA by incorporating BrdU into replicating DNA in place of thymidine. Next, theBrdUlabeled cells were encapsulated in the gel and incubated in stem cell culture medium to
form tumorspheres as described previously. At each time point, the retention of BrdU in
the encapsulated cells was imaged by immunofluorescent staining with antiBrdUantibodies as described [75]. At each time point, tumorspheres encapsulated in the
gel samples were processed and stained for immunofluorescent imaging of BrdU-labeled
cells or CD44 marker as described [76]. Gel samples were fixed and permeabilized for 3
h at 4°C in PBScontaining 4% paraformaldehyde and 1% Triton X-100, followedby
rinsing with PBS (3×10 min). Tumor spheroidswere then dehydrated in an ascending
series of methanol at4°C in PBS (25%, 50%, 75%, and 95% for 30 min each and 100%
for 5 h) and rehydrated in the same descending series andwashed in PBS
(3×10 min). Next, samples were blocked withPBS containing 0.1% Triton X-100
(PBST) and 3% BSA overnightat 4°C and washed with PBS (2 × 15 min). Then,
sampleswere incubated with primary antibodies (anti-CD44 antibodyor anti-BrdU
antibody) diluted in PBST on a gently rockingrotator at 4°C overnight followed by
rinsing with PBST(4 × 30 min). Samples were then incubated with Alexa Fluor–
conjugated secondary antibodies for 2 h and rinsed with PBST
(4× 10 min). The cell nuclei were counterstained with DAPI(1:5000 dilution in PBS) and
imaged with a Nikon Eclipse Ti-einverted fluorescent microscope.
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2.6 RNA ANALYSIS
Total cellular RNA of the gel samples was isolated using TRIzol (Invitrogen) as
described [73]. About 250 ng of the extracted purified RNA was reverse transcribed to
cDNA by SuperScript II Reverse Transcriptase (Invitrogen) with the random primers.
The obtained cDNA was subjected to realtime quantitative polymerase chain reaction
(RT-qPCR) amplification with appropriate gene-specific primers. RT-qPCR was
performed to analyze the differential expression of CSC markersgenes with SYBR green
RealMasterMix (Eppendorf, Hamburg, Germany) using Bio-Rad iCycler PCR system
(Bio-Rad, Hercules, CA). The expression level of GAPDH gene was used as an internal
control.

The

primers

for

RT-PCR

were

designed

by

Primer

3

software

(http://frodo.wi.mit.edu). The forward and reverse primer sequences, listed in Table
2.1.The relative gene expression levels were quantified by the 2–DDCT method as
described [77, 78]. The relative gene expression was expressed asfold difference
compared with that at time zero.
2.7 MICROPATTERN FABRICATION
Briefly, 40 µL of the gel precursor solution (without cells and peptides) was transferred
onto a glass base between two tape spacers (separated by 2 cm) and covered with a glass
slide. Upon hydrogel crosslinking under UV irradiation for 8 minutes, the cover was
removed and the gel was washed with PBS five times to remove the unreacted
macromers. The second layer was fabricated by thickening the spacer with placing
another tape layer, transferring 40 µL of the gel precursor solution on top of the first
layer, crosslinking of solution for 8 minutes and washing the gel five times. The masks
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were designed using Autocad software and printed on a transparent paper. MDA-MB-231
cells were suspended in gel precursor solution and transferred on the gel layer.
Table 2.1 The forward and reverse primer sequences
PCR Primer

Forward Sequence

Reverse Sequence

mGAPDH

CATGGCCTTCCGTGTTCCTA´

CCTGCT TCACCA CCT TCTTGA´

hGAPDH

GAGTCAACGGATTTG GTCGT

TTGATTTTGGAGGGATCTCG

mCD44

GAATGTAACCTGCCGCTACG´

GGAGGT GTT GGA CGT GAC´

mABCG2

AGCAGCAAGGAAAGATCCAA´

GGAATACCGAGGCTGATGAA´

mSCA1

TGGACACTTCTCACACTA-

CAGAGCAAGAGGGTCTGCAGGAG

mCD24

CTTCTGGCACTGCTCCTACC

GAG AGAGAG CCAGGAGACCA´

hCD44

GGCTTTCAATAGCACCTTGC

ACACCCCTGTGTTGTTTGCT

hABCG2

CACCTTATTGGCCTCAGGAA

CCTGCTTGGAAGGCTCTATG’

hCD133

GCATTGGCATCTTCTATGGTT’

CGCCTTGTCCTTGGTAGTGT

h Oct4

CGCCGTATGAGTTCTGTG’

GGTGATCCTCTTCTGCTTC’

hTGFb

CCGGAGGTGATTTCCATCTA’

CTCCATTGCTGAGACGTCAA’

hEGFR

CAGCGCTACCTTGTCATTCA

TGCACTCAGAGAGCTCAGGA’

The spacers were thickened and the mask was placed on top of the spacers and was
pressed flat by a glass slide. After 5 minutes UV crosslinking of the sample, the mask
was removed; the gel was washed three times and was cured for 3 minutes under UV.
The patterned gel was then washed three times with PBS, removed from the glass base
and transferred to the media.
2.8 PEPTIDE SYNTHESIS AND CHARACTERIZATION
CD44 binding peptide (CD44bp), integrin-binding peptides (Ibps), and heparin-binding
peptide (Hbps) as well as their mutants, selected according to previous reports [79-81],
were synthesized peptides manually on Rink Amide resin in the solid phase using a
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previously described procedure [82]. The sequences of these peptides and their mutants
are listed in Table 2.2.
Table 2.2 Peptides sequence and the origin

Peptide Name
FC/HV
HepI
HepIII
I1
I2
I3

Sequence
WQPPRARI-Ac
TAGSCLRKFSTMY-Ac
GEFYFDLRLKGDKY-Ac
GRGDS-Ac
IKVAV-Ac
YIGSR-Ac

Protein of Origin
Fibronectin
Collagen IV
Collagen IV
Fibronectin
Laminin
Laminin

Briefly, the Fmoc-protected amino acid (6 eq.), DIC (6.6 eq.), and HOBt (12 eq.) were
added to 100 mg resin and swelled in DMF (3 mL). Next, 0.2 mL of 0.05 M DMAP was
added to the mixture and the coupling reaction was allowed to proceed for 4-6 h at 30°C
with orbital shaking. The resin was tested for the presence of unreacted amines using the
Kaiser reagent [82]. If the test was positive, the coupling reaction was repeated.
Otherwise, the resin was treated with 20% piperidine in DMF (2×15 min) and the next
Fmoc-protected amino acid was coupled using the same procedure. After coupling the
last amino acid, the peptides were functionalized with an acrylamide group directly on
the peptidyl resin by coupling acrylic acid to the N-terminal amine group under
conditions used for the amino acid coupling reaction [82]. The acrylamide-terminated
peptide was cleaved from the resin by treating with 95% TFA/ 2.5% TIPS/ 2.5% water
and precipitated in cold ether. The acrylamide-terminated (Ac) peptides were further
purified by preparative HPLC on a 250 x 10 mm, 10 µm Xterra Prep RP18 column
(Waters, Milford, MA) with a flow rate of 2 mL/min using a gradient 5–95% MeCN in
0.1% aqueous TFA at detection wavelength of 214 nm. The HPLC fraction was
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lyophilized and the product was characterized with a Finnigan 4500 Electro Spray
Ionization (ESI) spectrometer (Thermo Electron, Waltham, MA).
2.9 FLOW CYTOMETRY ANALYSIS
Cells encapsulated in the gel were fixed with 4% paraformaldehyde for 30 min followed
by washing with PBS. Next, the gel was incubated in oxidative degradation solution
(0.1M CoCl in 20% hydrogen peroxide) [83]. After the gel was degraded, cells were
washed three times with cold PBS containing 5% BSA. MCF7 cells were incubated with
phycoerythrin (PE) mouse anti-human CD24 and fluorescein isothiocyanate (FITC)
mouse anti-human CD44 (BD Biosciences, Franklin Lakes, NJ), and 4T1 cells were
incubated with PE-anti-mouse CD24 and FITC-anti-mouse CD44 (eBioscience, San
Diego, CA) in 100 µl PBS with 5% BSA for 45 min on ice in dark. Cells were then
washed with cold PBS with 5% BSA three times and analyzed by a flow cytometer
(FC500, Beckman Coulter, Brea, CA). Flow cytometry was done multiple times on each
sample to ascertain reproducibility of the results.
2.10 WESTERN BLOT
The cell encapsulated gel was washed with PBS and homogenized in RIPA buffer (1%
NP40, 1% SDS, 150mM NaCl, 20mM Tris-Cl pH7.4, 1mM EDTA protease inhibitors) to
extract the proteins. The homogenized sample was centrifuged for 5 min to isolate total
proteins. Next, proteins were separated by standard SDS-PAGE using Mini-gel system
(Bio-Rad) and transferred to a nitrocellulose membrane by the semi-dry transfer
apparatus (Bio-Rad). Membranes were incubated in the blocking buffer (5% fat-free dry
milk in TBST buffer) at ambient conditions for 1 h followed by incubation with primary
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antibodies (1:200-1:2000) overnight at 4oC. After washing, the membrane was incubated
with HRP-conjugated secondary antibodies for 1 h at ambient conditions. After extensive
washing with TBST, the membrane was incubated with ECL detection reagents and
exposed to an X-ray film. The intensity of the band was quantified with the Image-J
software (National Institutes of Health, Bethesda, MD).
2.11 STATISTICAL ANALYSIS
Data are expressed as mean +/- standard deviation. All experiments were done in
triplicate. Significant differences between groups were evaluated using a two-way
analysis of variance (ANOVA) with replication test followed by a two tailed Student’s ttest. A value of p < 0.05 was considered statistically significant.
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CHAPTER 3
RESULTS AND DISCUSSION
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3.1 EFFECT OF CELLS NUMBER DENSITIES ON TUMORSPHERES
FORMATION IN HYDROGEL
MDA-MB-231 tumor cells with initial number densities of 0.3, 0.6, 1, 1.5 and, 2 (106 /ml)
were encapsulated in 5kPa PEGDA hydrogels and cultured in stem cell medium for 9
days.Fluorescent images in Figure 3.1 show the extent of cell aggregation and spheroid
formation after 9 days (column 2) for MDA-MB-231 encapsulated cells with initial
number densities (column 1) of 0.3 (Fig 3.1, row 1), 0.6 (Fig 3.1, row 2), 1 (Fig 3.1, row
3), 1.5 (Fig 3.1, row 4) and 2 (Fig 3.1, row 5) (106 /ml). Spheroid formation was
observed in two initial number densities of 0.6 and 1 (106/ml). While cells with low
initial density of 0.3 (106/ml) did not change significantly in morphology, densities of 1.5
and, 2 (106/ml) showed significant increase in the number and shape of cells aggregates
during 9 days.
The number density of viable cells is shown in Figure 3.1B. Although, the cell count did
not increase in the group with 0.3 (106/ml) of cells, it increased with time for the other
groups after 9 days. This change was bimodal that the cell count initially increased about
4 and 5 times in the groups with densities of 0.6 and 1 (106/ml) respectively and then
decreased to 3 times for cells with initial densities of 1.5 and 2 (106/ml) suggesting that
the highest potential for growth was observed in the groups with the ability of
tumorspheroids formation.
The expression of breast CSC markers for tumorspheres and cell aggregates grown in
PEGDA gels with different cell number densities is shown in Figure 3.1 C–E. Cells with
0.6 and 1 (106 /ml) initial number density had the highest expression of all markers
suggesting that sphere formation was correlated with the expression of CSC markers. The
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CD44 expression initially increased and reached a maximum at the cell number density
of 1 (106 /ml) then decreased sharply for higher densities at both timepoints of 6 and 9
days. The highest expression of ABCG2 and EGFR markers were observed in the group
with 0.6 (106 /ml) density which formed larger sizes of tumorspheroids compared to the
group with 1 (106 /ml) density. Aggregates in the groups with high cell number densities
showed very low fold expression of these two markers at both timepoints. Therefore, the
biphasic behavior was also observed for these two markers that the fold expression of
markers had a decreasing trend for the cell densities higher than 0.6 (106 /ml). The CSC
expression in the group with low cells density of 0.3 (106 /ml) did not increase
significantly in 9 days of incubation and remained in a very low level.
Increasing the cell number density will directly affects the quantity and level of cell-cell
interaction and may affect the fate of encapsulated cancer cells. Although normal and
cancer stem cells regulate similar signaling pathways to keep their stemness, their degree
of dependency to the environmental cues including neighboring cells is totally different.
Under normal conditions, the microenvironment provides transient signals for both
proliferation and differentiation of stem cells and plays a critical role to maintain their
stemness. On the other hand, CSCs due to the mutations, are self-sufficient with respect
to proliferation [37, 38]. CSCs do not need to be in tight junctions with their surrounding
cells to grow and form tumorspheroids in vitro. Encapsulation of epithelial cancer cells
harvested from 2D culture plates in form of aggregates eliminates the chance of spheroid
formation. This may be explained by the fact that cells in form of aggregates with apical
and basal surfaces remain polarized after being cultured in PEG hydrogels. However,
culturing cells individually at an appropriate number density leads regular cancer cells to
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lose their polarity and ECM adhesion tendency resulting in development of CSCs-like
properties accompanied with sphere formation. This loss of polarity inhibits the growth
of polar non-CSCs. Consistent with this notion, Epithelial to Mesenchymal Transition
(EMT), one of the main biological events involved in tumor spheroids formation needs
cells to lose their polarity. [39-41]. Besides, the direct cell-cell contact between cells act
as a barrier to the diffusion of small signaling molecules vital for induction of CSC-like
properties through the intercellular space [16].
Signaling pathway involved in CSCs progression, may not need the tight junction of cells
to be regulated but still need close communication of cells together i.e., culturing cells at
a very low number density of 0.3 (106 /ml), prevents cells to receive the signals of
adjacent cells.
High expression of CD44 as the most important marker for breast CSCs identification
correlates to formed tumorspheroids with higher population of CSCs compared to groups
with single cells or aggregates. The larger diameters of spheroids in groups with 0.6 (106
/ml) cells showed higher expression of EGFR and ABCG2 markers which may be related
the higher level of cell-cell interaction in larger spheroids.
3.2 EFFECT OF MATRIX MODULUS AND TOPOGRAPHY ON STEM CELLS
AND TUMORSPHERE FORMATION
3.2.1 HYDROGEL MODULUS
Disk-shaped hydrogels with 8mm diameter and 750mm thickness were fabricated for
determination of elastic modulus and cell encapsulation. The effect of macromer
concentration and incubation time on the elastic modulus of PEGDA hydrogel is shown

26

in Figure 3.2. Macromer concentration in the precursor solution affected the elastic
modulus of the hydrogel. The elastic modulus increased from 2 to 70 kPa as the

Figure 3.1 Evolution of tumorsphere formation in different number densities Cells
Encapsulated in PEGDA hydrogels with number densities of 0.3, 0.6, 1, 1.5, 2 (106 /ml) (Rows 1
to 5) as a function of incubation time. Columns 1and 2 correspond to incubation times of 0 and 9
days, respectively. At each time point, encapsulated cells were stained with Phalloidin for
cytoskeleton (red) and DAPI for nucleus (blue), and imaged with an inverted fluorescent
microscope (A) Cells density (B) CD44 fold expression (C), ABCG2 fold expression (D), and
EGFR fold expression (E)
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macromer concentration was increased from 5% to 10%, 15%, 20%, and 25%,
respectively.

Figure 3.2 Effect of macromer concentration on elastic modulus of PEGDA gels with time
3.2.2 TUMORSPHERE CHARACTERIZATION
Tumorsphere formation on ultra-low-attachment plates is a commonly used method to
enrich CSCs in vitro, while the gold standard for characterization of CSC tumorspheres is
by the ability to form tumor in vivo [69, 70]. 4T1-Luc cells were cultured on regular
adhesion plates or ultra-low-attachment plates. After one week, cells in monolayers
(adhesion plates) and in spheres (ultra-low-attachment plates) were collected and
subcutaneously inoculated in syngeneic Balb/c mice.
Tumor formation in mice was determined by imaging the expression of luciferase one
week after inoculation. Figure 3.3 compares tumor formation by cells on adhesion plates
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(Fig 3.3 A) and cells from tumorspheres on ultra-low-attachment plates (Fig 3.2 B). The
left and right images in Figure 3.3 A are for 5000 and 50,000 4T1-Luc cells on adhesion
plates. The left, center, and right images in Figure 3.3 B are for 500, 1000, and 5000 4T1Luc cells

Figure 3.3 Comparing in vivo tumor formation of 4T1 cells from adhesion plates (A) with
4T1 cells from tumorspheres on ultralow-attachment plates (B). The left and right images in
(A) show tumor formation by inoculation of 5000 and 50,000 4T1-Luc cells, respectively. The
left, center, and right images in (B) show tumor formation by inoculation of 500, 1000, and 5000
4T1-Luc cells from tumorspheres. 4T1-Luc cells were inoculated subcutaneously in Balb/c mice.
After one week, the expression of luciferase in tumors was imaged. The light blue, dark blue and
red color images correspond to low, medium, and high luciferase intensity, proportional to the
size of the tumor formed.

from tumorspheres on ultra-low-attachment plates. According to the images in Figure 3.3,
1000 tumorsphere cells were sufficient to form a tumor in vivowhile it required 50,000
regular tumor cells to form a tumor. These results demonstrate that tumorspheres formed
by 4T1cells in vitro had enriched CSC subpopulation.
3.2.3 TUMORSPHERE FORMATION IN HYDROGEL
In modulus study, we have focused on encapsulation of 4T1 mouse breast cancer cell line
and human carcinoma cells including MCF7, MDA-MB-23 (Breast), HCT116 (Colon),
AGS (Gastric) and U-2 OS (Bone) cancer cell lines. Cell lines were cultured in stem cells
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medium up to 14 days at different PEGDA hydrogels moduli ranging from 2 to 70 kPa.
MCF10a, a normal human breast epithelial cell line was encapsulated in 5 kPa modulus
gel and used as control to be compared with the cancer cell lines by their sphere
formation ability. Tumor spheroids are a 3D representative of the CSCs population and a
level of malignancy of cancer cells, in vitro[84].4T1 tumor cells were encapsulated in
PEGDA hydrogels with elastic moduli ranging from 2 to 70 kPa and cultured in stem cell
medium for 2 weeks. Images of live and dead cells 2 days after encapsulation in PEGDA
gels with moduli of 2, 5, 25, and 50 kPa are shown in Figure 3.4 A through 3D,
respectively. Based on image analysis, the percent viable cells for 2, 5, 25, 50, and 70kPa
gels were 94±4, 91±3, 92±3,90±4, and 89±4, respectively. These results show that the gel
modulus did not have a significant effect on viability of 4T1 cells after encapsulation. To
determine cell uniformity and viability, a confocal microscope was used to image cells in
the direction of thickness and the results are shown in Figure 3.5 E1±E8. Images in
Figure 3.4 E show uniform cell seeding and cell viability within the gel in the thickness
direction.
Fluorescent images in Figure 3.5 show the extent of cell aggregation and spheroid
formation with incubation time for 4T1 gels with modulus of 2 kPa (Fig 3.4, column 1), 5
kPa (Fig 3.4, column 2), 50 kPa (Fig 3.4, column 3).Rows 1, 2 and 3 in Figure 3.5
correspond to incubation times of 5, 8, 11, and 14 days, respectively. Spheroid formation
was observed in soft gels with moduli of 2 and 5 kPa as early as day 5 (columns 1, 2 in
Fig 3.4) while cells in the more stiff gels with modulus of 50 kPa and higher remained as
single cells or small cell aggregates (< 25 µm). At any time point, size of the
tumorspheres in the 5 kPa gel was higher than that of 2 kPa gel.
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Figure 3.4 Live (green) and dead (red) image of 4T1 cells 2 days after encapsulation in
PEGDA hydrogels with moduli of (A) 2 kPa, (B) 5 kPa, (C) 25 kPa, and (D) 50 kPa. The
scale bar in images (A–D) is 200 mm. Based on image analysis, the percent viable cells for 2, 5,
25, 50, and 70 kPa gels was 94 ± 4, 91 ±3, 92 ± 3, 90 ± 4, and 89 ± 4, respectively. Images (E1–
E8) on the right show the uniformity of cell seeding and cell viability in successive 90 mm layers
in the direction of thickness for 5.3 kPa gel obtained with a confocal fluorescent microscope. The
scale bar in images (E1–E8) is 200 μm.

Lower magnification images showing the number density of 4T1 (Fig 3.5, column 1) and
MCF7 (Fig 3.5, column 2) tumorspheres in PEGDA gels with elastic moduli of 2 kPa
(Fig 3.5, row 1), 5 kPa (Fig 3.5, row 2), 25 kPa (Fig 3.5, row 3), and 50 kPa (Fig 3.5,
row 4) after 8 days of incubation are shown in Figure 3.6, respectively.According to
Figure 3.6, the tumorsphere size and number density initially increased with increasing
matrix modulus from 2 to 5 kPa and then decreased when modulus was increased to 25
and 50 kPa. Tumorspheres with diameter >100µm were observed only in the gels with
modulus of 2 and 5 kPa but the fraction of large tumorspheres (> 100 µm) was
significantly higher in the 5 kPa gel.
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Figure 3.5 Evolution of tumorsphere formation by 4T1 tumor cells encapsulated in
PEGDA hydrogels with elastic modulus of 2 kPa (left column), 5 kPa (center left column),
and 50 kPa (right column) as a function of incubation time. Rows 1, 2, 3, and 4 correspond to
incubation times of 5, 8, 11, and 14 days, respectively. At each time point, encapsulated cells
were stained with Phalloidin for cytoskeleton (red) and DAPI for nucleus (blue), and imaged with
an inverted fluorescent microscope.

It should be noted that the size of MCF7 spheroids in the gels was less than that of 4T1.
The evolution of tumorsphere for human cell lines is presented in Figure 3.11.
Fluorescent images in Figure 3.11 A show the optimum modulus for spheroid formation
of each cell line as a function of time. The optimum moduli in columns 1 to 6 correspond
to 5, 5, 5, 25, 50 and, 25 kPa, respectively. At these moduli the single-cells fraction of
cancer cells started to form tumor spheroids after 6 days of encapsulation. Deviations
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from optimum stiffness led to reduction of the size and number of the formed
tumorspheres in each cell line (Fig 3.11 C, D). For example MCF7 and MDA-MB-231
cell lines formed the largest and most number of spheroids in their optimum modulus of 5
kPa at each time pointwhich is similar to the moduli of breast tumor tissues reported in
the literature [85]. Tumorspheres formed in the softer gels (with modulus of 2 kPa) were
smaller in size and
number and cells in the stiffer gels (25 kPa and higher) did not form spheres and
remained as single cells or small colonies (< 25 µm). The highest number and diameter of
spheroids in HCT116 and AGS cancer cell lines was observed in 25 kPa. In the case of
U-2 OS cell line the spheroid formation maximized at 50 kPa. As illustrated in Figure
3.11 D, for HCT116 and AGS cell lines increasing the matrix modulus up to 25 kPa
increased the number of formed spheres 6 and 4 times, respectively . However, further
increase of matrix modulus reduced the number and the size of spheres. Similarly, the
highest number and size of formed spheroids for U-2 OS cell line observed at an
optimum modulus of 50 kPa.
The effect of hydrogel modulus on average tumorsphere diameter and size distribution
with incubation time is shown in Figure 3.7 A and B for 4T1 cells, respectively. The
average 4T1 tumorsphere diameter increased from 10 μm at day zero to 80, 140, 30, 15,
and 10 μm after 14 days as the gel modulus increased from 2 kPa

to 5,25, 50 and

70 kPa respectively. For 4T1 cells in the softest gel (2 kPa modulus), 25% of the cell
aggregates at day 8 had <20 µm size (single-cell fraction) while there was no single-cell
subpopulation in the gel with 5 kPa modulus. Further, for the gel with 5 kPa modulus,
23% and 8% of 4T1 tumorspheres had size in the range of 80–120 and 120–200 µm,
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Figure 3.6 Representative images of tumorsphere density for 4T1 (left column) and MCF7
(right column) cells encapsulated in PEGDA hydrogels with elastic modulus of (A) 2 kPa
(first row), 5 kPa (second row), 25 kPa (third row), and 50 kPa (fourth row) after 8 days of
incubation. At each time point, encapsulated cells were stained with Phalloidin for cytoskeleton
(red) and DAPI for nucleus (blue), and imaged with an inverted fluorescent microscope.
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3.2.4 TUMORSPHERE SIZE AND NUMBER DENSITY

Figure 3.7 Average tumorsphere size (A), tumorsphere size distribution (B), and cell count
(C) for 4T1 tumor cells encapsulated in PEGDA hydrogels with different elastic moduli and
incubated for up to 14 days. The symbol asterisk indicates statistically significant difference
between the test group and all other groups at the same time point

respectively. The fraction of tumorspheres with 0–20μm diameter (single-cell fraction)
increased with increasing gel modulus for 4T1 cells and all of the cells in the highest
modulus gel (70 kPa) remained as single cells.
The number density of viable 4T1 cells in PEGDA gels with different moduli is shown in
Figure 3.7 C. The cell count increased with time for all groups but the gels with moduli
of 2 and 5kPa had the highest cell count at all-time points. At each time point, the change
in cell count with gel modulus was bimodal; that is, the cell count initially increased for
moduli of 2 and 5 kPa and then decreased for gels with moduli > 25 kPa. At day 14, the 5
kPa gel had 3-fold higher 4T1 cells than the 2 kPa gel; the 5 kPa gel had 10-fold higher
4T1 than those gels with > 25 kPa modulus. In general, the gel modulus has similar
effects on 4T1 cells. These results demonstrated that the gel with modulus of 5 kPa had
the highest potential for tumorsphere formation in the absence of ligand–receptor
interactions.
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The human cell number density at different moduli is shown in Figure 3.11 B. Although
the cell count in all groups increased after 9 days, the highest increase was observed in
the optimum modulus of each cell line. This caused a bimodal behavior in cell number
density of all cell lines i.e. the cell count increased up to the optimum modulus and
decreased with further modulus increase. This is notable in MDA, MCF7 and HCT116
cell lines.
The malignancy level of cancer cell lines can affect the density and size of tumorspheres.
For example, it has been shown that nonmalignant MCF10a epithelial cells are relatively
insensitive to the matrix stiffness within a wide range of stiffness while cancer cell lines
are sufficiently sensitive [86]. The size distribution of spheroids after 9 days shown in
Figure 3.11 E confirms this finding. MCF10a cells were almost non-sensitive to matrix
stiffness in the range of 2-70 kPa and 100% of cells had an average diameter less than 20
μm. On the other hand, MDA-MB-231 a triple negative breast cancer cell line, showed
the highest potential in cells aggregation and spheroids growth. No single-cell
subpopulation (less than 20 μm) of MDA-MB-231 cells was observed in the optimum
modulus of 5 kPa. Near 75% of the cells population were in the range of 60 to 80 μm for
this cell line whereas in MCF7 with a modest level of malignancy, only 20% of the cells
were in this range and about 60% of them were in the range of 40-60 μm.
In the optimized modulus of 25 kPa for HCT116 more than 70% of the spheroids were in
the range of 40 to 60 μm and about 5% of them were in range 60 to 80 μm. The singlecell fraction increased with increasing the optimum gel modulus. About 50% of spheroids
formed in AGS cell line were in the range of 20-40 μm. For U-2 OS about 60% of the
spheroids had diameters in this range. For both cases the rest of the spheroids had

36

diameters less than 22 μm (Fig 3.11 E).
One of the unique properties of CSCs is asymmetrical division and retention of DNA
labeling [70]. Based on this feature, BrdU retention is a commonly used method to
characterize CSCs. 4T1 cells were labeled with BrdU before encapsulation in the
PEGDA gel with 5 kPa modulus and the intensity of BrdU staining was compared with
those cells cultured on ultra-low-attachment plates. Figure 3.8 compares BrdU staining of
4T1 cells in suspension culture on ultra-low attachment plates (Fig 3.8 A, C) with those
encapsulated in PEGDA hydrogels (Fig 3.7 B, D). Images A and B in Figure 3.8 are after
8 days of culture while images C and D are after 14 days. After 8 and 14 days, cells
encapsulated in the gel displayed higher level of BrdU retention than those in suspension
cultures, suggesting that the encapsulated tumorspheres had higher fraction of CSCs.The
expression of breast CSC markers for tumorspheres grown in PEGDA gels with different
moduli is shown in Figure 3.9. Figure 3.9A–D shows the expression of CD44, CD24,
ABCG2, and SCA1 for 4T1 cells. ABCG2 of ABC transporter proteins is responsible for
CSC drug resistance and SCA1 (stem cell antigen-1) is a cell surface protein known to be
associated with breast CSCs [87-89]. CD44 and ABCG2 are well-studied markers in both
mouse and human breast CSCs [90, 91]. Although CD24 - is also a marker often used as
a breast CSC marker, recent studies indicate that both CD44 + /CD24 - and CD44 +
/CD24 + cells display CSC phenotypes in breast cancer cells [92]. 4T1 cells in the gel
with elastic modulus of 5 kPa had the highest CD44 expression and lowest CD24
expression for all time points. CD44 expression of 4T1 cells initially increased and
reached a maximum at day 8 for 2 and 5 kPa gels and at day 11 for 25 kPa gels. CD44
expression then decreased with incubation time. 4T1 cells encapsulated in the gels with
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3.2.5 Tumorsphere marker expression

Figure 3.8 BrdU staining of 4T1 tumorspheres formed in suspension culture on lowadhesion plates (A, C) and formed by encapsulation in PEGDA hydrogels (B, D). Images
(A) and (B) are after 8 days of incubation while images (C) and (D) are after 14 days. The
presence of BrdU in the cells was confirmed by immunofluorescentstaining (green). The cell
nuclei were stained with DAPI (blue).

moduli of 50 and 70 kPa did not show an increase in CD44 expression in 14 days. At day
8, CD44 and ABCG2 expression of 4T1 cells increased by 2.2 and 1.8 fold with increase
in gel modulus from 2 to 5 kPa, respectively. Figure 3.12 illustrates the effect of modulus
on the expression of two of these CSC markers for human cancer cell lines in time. CD44
has been extensively used in CSC identification and characterization for different human
cell lines [93-96].Figure 3.12 demonstrates the expression of CD44 and ABCG2 –an
ABC transporter protein that is responsible for breast CSCs drug resistance– in MCF7
cell line [87, 88].
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Figure 3.9 Effect of gel elastic modulus on the relative mRNA expression levels of CD44
(A), CD24 (B), ABCG2 (C), and SCA1 (D) markers of 4T1 cells encapsulated in PEGDA
hydrogels with incubation time. The mRNA expression levels of the markers for 4T1 cells
before encapsulation were used as reference (set equal to one).

MCF7 cells encapsulated in the gel with elastic modulus of 5 kPa expressed the highest
level of CD44 and ABCG2 proteins at both time points of 6 and 9 days. The expression
for these markers maximized in 5 kPa gels and then decreased sharply at stiffer gels. This
biphasic behavior was also observed in MDA-MB-231 breast cancer cell line. Cells had
the highest expression of CD44 and EGFR –a cell surface protein associated with CSCs
population– at 5 kPa and significantly lower expression in other moduli.
The expression of CD44 and TGFB –a main protein in colon CSCs progression– are
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Figure 3.10 Expression pattern of CD44 marker of 4T1 tumorspheres formed in
suspension culture on low-adhesion plates (column A) and formed by encapsulation in
PEGDA hydrogel with 5 kPa elastic modulus (column B). Images in rows 1, 2, 3, and 4 are
after 5, 8, 11, and 14 days of incubation, respectively. The cell nuclei were stained with DAPI
(blue).

shownin Figure 3.12. The fold expressions of these markers in the optimum modulus of
25 kPa were more than 3 times higher than the other moduli and the sharp decline from
optimum to other moduli is considerable.
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Figure 3.11 Evolution of tumorsphere formation by different tumor cell lines Cells
Encapsulated in PEGDA hydrogels with elastic moduli of 5,5,5,25,50, 25 kPa respectively (left to
right column) as a function of incubation time. Rows 1, 2, and 3 correspond to incubation times
of 2, 6 and 9 days, respectively. At each time point, encapsulated cells were stained with
Phalloidin for cytoskeleton (red) and DAPI for nucleus (blue), and imaged with an inverted
fluorescent microscope (A). Cells density (B) Average tumorsphere size (C), tumorspheres no.
density (D), and tumorspheres size distribution (E) for different tumor cell lines encapsulated in
PEGDA hydrogels with different elastic moduli and incubated for 9 days.

A similar behavior was observed for the CD44 and Oct4 markers of AGS cell line. The
expression of CD44 and Oct4 markers increased by 3 and 7 times,respectively, with
increase in gel modulus from 5 to optimum modulus of 25 kPa and decreased again by
1.8 and 2.3 fold with increase in gel modulus from 25 to 50 kPa (Fig 3.12). The
significantly higher fold expression of CD44 and CD133 markers for U-2 OS cell line in
50 kPa indicates that the expression of CSCmarkers inthe optimum modulus correlates
with spheroid formation and lack of this ability in cells of other modulistrongly affects
the expression of these important CSCs markers (Fig 3.12). Although the size and density
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of the spheroids are in correlation with CSCs markers expression, a biphasic behavior
was observed inall cell lines that CSCs markers expression rises when spheres start to
form but diminishes after a few days of growth.To determine whether tumorspheres in
the hydrogel had a higher level of stem cell population than those formed on ultra-lowattachment plates, CD44 immunostaining of the 4T1 cells encapsulated in PEGDA gels
(5 kPa modulus) was compared with those cultured on
ultra-low-attachment plates after 5, 8, and 11 days of culture, and the results are shown in
Figure 3.10. Tumorspheres grown in the gel and onultra-low-attachment plate both had
high level of CD44 staining after 5 and 8 days of culture and the intensity of CD44
staining started to decrease after 8 days of culture forboth groups. This was consistent
with our CD44 mRNA data (see Fig 3.8). However, tumorspheres grown in the gel had a
more intensive CD44 staining than those on ultra-low attachment plates for longer
incubation times of 11 and 14 days, suggesting that the 3D microenvironment and gel
stiffness modulated the maintenance of stemness in CSCs.
3.2.6 Micropattern fabrication
Topography of ECM is an important biomechanical factor that influences stem cells fate
[55]. Recent advances in studying mechanical properties of ECM allow researchers to
investigate the higher aspects of ECM biomechanics and their key role in stem cells fate.
In this work, layer by layer micropatterning technique was used to employ pre-defined
zones of cell encapsulation in PEG hydrogels and study the effect of spatial limitations on
the CSCs behavior. MDA-MB-231 cells were encapsulated in the micropatterned
hydrogels with optimized modulus of 5 kPa and cultured in stem cells medium up to 14
shown in Figure 3.14. The presented fluorescent images highlight the level of spheroid

42

days. Images of cell tracker stained cells in patterns with 75, 100, 150, and 250 m
diameters after 2 days of encapsulation are shown in Figure 3.13.

Figure 3.12 Effect of gel elastic modulus on the relative mRNA expression levels mRNA
expression of CSCs markers for MCF7, MDA-MB-231, HCT116, U-2 OS and AGS cell lines
encapsulated in PEGDA hydrogels with incubation time. The mRNA expression levels of the
markers before encapsulation in the gel were used as reference in all cell lines.

formation with incubation time for MDA-MB-231 cells in different sizes of
micropatterns with diameters of 75 m (Fig 3.13, row 1), 100 m (Fig 3.13, row 2), 150
m (Fig 3.13, row 3), and 250 m (Fig 3.13, row 4). Columns 1-3 in correspond to
incubation time periods of 2, 9, and 14 days, respectively. Although after 14 days of
encapsulation,the spheroids formed at all different sizes of micropatterns, a significant
change in the size of the formed spheres was observed (column 3 in Fig 3.14).
The evolution of cell number density and spheres size for MDA-MB-231 cells in
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Figure 3.13 Effect of patterns size on tumorsphere formation MDA-MB-231 cells
encapsulated in PEGDA patterned hydrogel with 5 kPa of elastic modulus and 75,100,150 and
250 micrometer of patterns diameter. Encapsulated cells were stained with cell tracker.

micropatterns at a time period of 2 weeks are presented in Figure (13 M, N). While the
number of cells in 75 or 100 micropatterns remained at a low level, the cell number
density of control (non-patterned hydrogel) or 250 m patternsincreased significantly
after 2 weeks (Fig 3.14 M) suggesting that the size limitation affects the rate of
proliferation in tumor cells. Similarly, the diameters of uniformly sized tumorspheres in
75 and 100 m patterns were consistently smaller than tumorspheres formed in control or
250 m patterns with various sizes of tumorspheres.After 14 days of encapsulation in the
gel, the average diameters of spheres formed in non-patterned gel and 250 m patterns
were approximately 20 and 40 m greater than those formed in 75 or 100 m,
respectively (Fig 3.14 N).
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Figure 3.14 Effect of patterns size on tumorsphere formation and the relative mRNA
expression levelsMDA-MB-231 cells encapsulated in PEGDA patterned hydrogel with 5 kPa of
elastic modulus. Pattern with 75  diameter after 2 days (A). Pattern with 75  diameter after 9
days (B). Pattern with 75  diameter after 14 days (C). Pattern with 100  diameter after 2 days
(D). Pattern with 100  diameter after 9 days (E). Pattern with 100  diameter after 14 days (F).
Pattern with 150  diameter after 2 days (G). Pattern with 150  diameter after 9 days (H).
Pattern with 150  diameter after 14 days (I). Pattern with 250  diameter after 2 days (J). Pattern
with 250  diameter after 9 days (K). Pattern with 250  diameter after 14 days (L). Cells density
(M) Average tumorsphere size (N) mRNA expression levels of different markers (O, P).

The expressions of breast CSC markers (CD44 and ABCG2) for cells encapsulated in
different sizes of micropatternsare shown in Figure 3.13 O, P. After 9 days of culturing,
CD44 fold expression increased nearly 60 times of the initial level in micropatterns of
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150 m and smaller then decreased slightly after 14 days. However, 40 and 30-fold
expression of this marker for 250 m and non-patterned hydrogel showed a sharp
decrease from 9 to 14 days Fig 3.14 O. Similarly, in case of 250 m and control group
the expression of ABCG2 marker increased significantly in the first 9 days followed by a
sudden decrease Fig 3.14 P suggesting that spheroids with consistent diameters may
expand the population of CSCs in the same culture and maintain stemness properties for a
longer time compared to traditional methods of culturing tumor spheroids.
Recent advances in cancer research have highlighted the importance of CSCs interaction
with the ECM at cellular and molecular level. The ECM stiffness regulates proliferation
and differentiation of many cell types [97-99]. Earlier studies demonstrated that
increasing ECM stiffness deregulates cellular functions and causes cancer development.
On the other hand, decreasing the rigidity and normalizing the tensional homeostasis can
return them to normal conditions. For example, the stiffness of cancerous breast tissue is
20 times higher than that of normal tissue with approximate rigidity of 0.2 kPa [100].
Deviations in the mechanical properties of the normal tissues not only affects the shape
and morphology of the cells, but also cause phenotypic and functional changes, e.g. while
proliferation and morphogenesis of normal mammary epithelial cells tune with soft ECM
cells interacting with progressively stiffening cancerous tissue become more contractile
in morphology and over-responsive to environmental cues [57,58]. The malignancy level
of cancer cell lines can affect the density and size of tumorspheres. For example, it has
been shown that nonmalignant MCF10a epithelial cells are relatively insensitive to the
matrix stiffness within a wide range of stiffness while cancer cell lines are sufficiently
sensitive [60]. The size distribution of spheroids after 9 days shown in Figure 3.11 E
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confirms this finding. MCF10a cells were almost non-sensitive to matrix stiffness in the
range of 2-70 kPa and 100% of cells had an average diameter less than 20 μm. On the
other hand, MDA-MB-231 a triple negative breast cancer cell line, showed the highest
potential in cells aggregation and spheroids growth. No single-cell subpopulation (less
than 20 μm) of MDA-MB-231 cells was observed in the optimum modulus of 5 kPa.
Near 75% of the cells population were in the range of 60 to 80 μm for this cell line
whereas in MCF7 with a modest level of malignancy, only 20% of the cells were in this
range and about 60% of them were in the range of 40-60 μm. These results suggest that
the response of cancer cells to matrixstiffness is not only dependent on the cancer but
also on malignancy of the cancer. Further, it has been reported that nontumorigenic breast
epithelial cells loose cell polarity and increase proliferation when cultured in matrices
with 4.5 kPa stiffness [37]. Inaddition, normal murine mammary gland or welldifferentiated mammary epithelial cells cultured in high-density collagen matrices display
an invasive phenotype [101].Cells respond to the mechanical properties of their ECM in
different hydrostatic, tensional or compressional levels [44]. The dynamic balance
between the intercellular and external forces results in the formation of interfacial stresses
between the microenvironment and the cytoskeleton. These forces enable cells to sense
cell-cell or cell-matrix resistance leading to the regulation of certain physicochemical
pathways [101, 102]. Tumorogensis mechanisms originate from the accumulation of
membrane proteins, conformational changes, cytoskeletal contraction, and re-distribution
of subcellular components. Direct sensing of cytoskeletal tensions originated mainly from
actin stress fibers may be another possible contributor to re-distribution of subcellular
components and activation of tumorigenic mechano-transductive pathways. Certain
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proteins and ion channels present on cell membranes also initiate cell sensing of ECM
mechanics leading to ion fluxes and additional biochemical effects [25]. The cell
response to stiffness in the inert PEG matrix may be through the ECM secreted by the
encapsulated tumor cells. For example, human mesenchymal stem cell (hMSCs)
encapsulated in PEG hydrogels, in the absence of adhesive ligands, secret their own ECM
through which differentiation is directed by mechanotransduction[103].According to
rubber elasticity theory, the gel elastic modulus is proportional to the density of
elastically activechains or crosslink density[104]. The network crosslink density
increased with increasing acrylate concentration in PEGD precursor solution, leading to
the increase in matrix modulus. The range of elastic moduli selected in this study was
based on the reported stiffness of breast tumor tissue [85, 100].Increasing evidence
suggests that CSCs are responsible for tumor initiation and metastasis as well as drug
resistance [105].Maintenance of CSCs in vivo is highly dependent on the tumor
microenvironment.
Stem cell microenvironments in vivoare polarized structures with individual stem cells
exposed to different niche components [106, 107]. We have shown in this study that the
formation of spheroids by tumor cells encapsulated in an inert matrix is biphasic with
respect tomatrix modulus in the 2–70 kPa range. The initial increasein tumorsphere size
and cell number density with elasticmodulus may be attributed to a deviation from
normal tissuestiffness leading to matrix reorganization andchange in the number and
lifetime of integrin-mediated interactionsand related pathways[59]. It has been reported
thatthe sphere size of breast cancer cells encapsulated in collagengels increased with
elastic modulus from 0.17 to 1.20 kPa [37].In another study, it was shown that the
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proliferation andsphere size of hepatocellular carcinoma cells encapsulated inPEG–
collagen gels increased with decreasing elastic modulusfrom 4 kPa (corresponding to the
modulus of healthy liver) to0.7 kPa.70 A decrease in sphere size and cell number for
gelmoduli > 5.3 kPa can be attributed to a decrease in mesh sizeand increase in retractive
force of the gel network, leading toa negative contribution on the cell proliferation and
sphereformation[108].Variety of size and density in formed tumorspheres of each cell
line may also be attributed to the fact that the stiffness of PEG hydrogel network
increases with decrease in the mesh size. By increasing macromer concentration in the
range of 2 to 70 kPa, the mesh size decreased sharply from 90 to 25 nm. The reduction in
mesh size may hinder the diffusion of nutrients or oxygen and restrict the motility and
proliferation ability of the cells[109-111]e.g., the size and density of the tumorspheres
formed by U-2 OS cell line at 50 kPa were smaller compared with MCF7 breast
tumorspheres formed at 5 kPa. Therefore, the bimodal effect of gel modulus on
tumorsphereformation may be due to the changes in the network meshsize, as well as the
gel modulus, that can affect cell–matrixinteractions and nutrient diffusion.The formation
of tumorspheres is associated with breastCSC markers, suggesting that sphere formation
in the gelmatrix is not caused by simple cell aggregation but by CSCs.It has been shown
that matrix stiffness can alter the expressionof CSC markers in hepatocellular carcinoma
cells encapsulate in a collagen matrix [51]. Unlike collagen and other biological gels,
varying PEGDA macromer concentration only changes the gel stiffness, not the ligand
density in thematrix. Our results suggest that the stiffness of the tumor tissue alone is
sufficient to affect the fate of tumor cells. A biphasic behavior of CSC marker expression
with time may be attributed to the fraction of CSCs in the gel. The CSC fraction initially
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increased with loss of normal tumor cells in the inert low-adhesive PEGDA gel. Then, the
fraction started to decrease as the rate of differentiation of CSCs to normal cancer cells
was higher than the rate of transformation ofdifferentiated cells to CSCs[112]. The
highest expression ofCSCs markers at day 8 and 9 with largest tumorspheresize for
cancer cells encapsulated in the gel withoptimum modulus indicates the existence of
highest fraction of stem-like subpopulation at this matrix modulus. The fraction of CSCs
in a tumor also depends on the microenvironment[105]. The concentration of oxygen and
nutrients in the center of large tumorspheres may be lower than that for small spheres,
leading to the formation of a hypoxic condition in the central part of the spheres in the
gel, which in turn can increase the expression of CSC markers[105, 111]. Naturally
derived gels, such as alginate and agarose gels, have also been used to study the behavior
of breast cancer cells under a 3D condition. For example, highly invasive rat mammary
carcinoma MTLn3-Mena cells form tumorspheres when encapsulated into alginate
hydrogels, and the formation of tumorsphere can be inhibited by coculture with
embryonic stem cells [26]. In another study, encapsulation of neoplastic cells in a
growth-restricting hydrogel composed of agarose matrix leads to the selection of a stem
cell subpopulation and the formation of tumorspheres[27]. However, our work
demonstrates for the first time that CSCs can be maintained in the inert
microenvironment of synthetic PEG hydrogels and the elastic modulus of the gel affects
the growth of tumorspheres. The growth and maintenance of CSCs in other synthetic
gels, such as polyhydroxyethyl methacrylate, polyvinylpolypyrrolidone, and polyvinyl
alcohol, is of interest and will be investigated in future works. Our results also show that
cancer cells form higher number of tumorspheres when encapsulated in the PEG hydrogel
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compared with suspension cultures on low-adhesion plates. There are two possible
explanations for this observation. One explanation is that the 3D hydrogel culture system
more closely mimics the in vivo tissue environment than the suspension cultures with
respect to the survival of CSCs. Evidence supporting this notion is that cancer cells have
fewer number of CSCs in 2D cultures than the in vivo[27]. The elastic retroactive force of
the gel network can promote viability and proliferation of CSCs by enhancing specific
proteins activation [113, 114]. The other explanation is that the retroactive force of the
gel can induce the transformation of differentiated bulk cancer cells into CSCs. The
transformation between CSCs and differentiated cancer cell is not unidirectional. Recent
studies indicate that inducing epithelial-to-mesenchymal transition (EMT) is sufficient to
transform a differentiated cancer cell into a CSC [115, 116]. In the process of EMT,
tumor cells undergo cytoskeletal reorganization with subsequent changes in cell
adhesion. At the molecular level, the key features of EMT include the altered expression
of cell membrane proteins, such as E-cadherin and b-catenin, and cell polarity. It is
known that mechanical properties as well as biochemical composition in the tumor
microenvironment play profound roles in EMT [117, 118]. It is possible that the hydrogel
stiffness shifts the balance of EMT by regulating the conformation of cell membrane
receptors and cell polarity. One example of such mechanism is epidermal growth factor
receptor (EGFR) signaling that has been associated with breast CSC maintenance [119].
Compression of the cell membrane by the gel refractive force can shrink the interstitial
space and increase the local ligand and receptor concentrations, thus increasing the
autocrine EGFR signaling [120]. Several signal transduction pathways, such as Notch,
Wnt, and Hedgehog, have been identified to be critical for CSC maintenance[121]. It is
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unclear how these pathways are regulated by the matrix modulus as these pathways are
normally activated by ligand binding to cell surface receptors, which was absent in
PEGDA gels. A possible explanation is receptor clustering induced by compression of
the cell by the elastic retractive force of the gel network. Future work should focus on the
effect of gel modulus, in the absence of ligand–receptor interaction, on the expression
and activity of the components of these pathways and how stiffness modulated
tumorsphere formation is altered when these pathways are blocked. It should be
mentioned that the effect of matrix modulus on viability, growth, and differentiation of
normal stem cells has been investigated. For example, the fate of MSCs encapsulated in
alginate or agarose gels conjugated with cell-binding RGD peptides is regulated by the
elastics modulus of the matrix. The encapsulated MSCs differentiated to the osteogenic
lineage in the gel with an intermediate modulus (11–30 kPa) while they differentiated
into the adipogenic lineage in the gel with a low modulus (2.5–5 kPa).26 Similarly,
MSCs encapsulated in PEG–silica gels with an intermediate elastic modulus (10–30 kPa)
display edosteogenic phenotype [86]. It appears that matrix modulus affects the
differentiation of normal stem cells while it affects maintenance and growth of
tumorspheres in the case of CSCs. In this work, the effect of matrix modulus on
tumorsphere formation and maintenance of CSCs was investigated in an inert matrix
without the interference of other factors.
In vivo, the geometrical constraints of the niche controls geometry, morphology and
functionality of the stem cells [55][94, 97]. However removing the cells from their native
tissue and culturing them in vitro culture systems will hinder the microenvironmental
interactions and their relevant functionalities. Thus, culturing cancer cells in confined
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areas of micropatterns may provide a useful model to mimic the spatial limitations of
ECM and neighboring cells [55].
PEGDA micropatterned hydrogel defines an in vitro culture system that controls the
proliferation and size of tumorspheres. The size of tumorspheres is a critical factor in
maintenance of CSCs properties. The spheres with large diameters act as a barrier for
soluble oxygen and nutrients and may lead to stem cells differentiation. Spheroids with
consistent size and homogeneous population of cells may be used as a reliable model in
different studies such as investigating the diffusion gradients of soluble factors across the
spheroids [55, 122].
PEGDA hydrogels may be introduced as an inert 3D microenvironment for studying the
individual effects of different parameters (including the modulus) on the survival and
maintenance of 4T1 murine breast CSCs. The current study showed that the effect of
elastic modulus is not limited to 4T1 cancer cells but extends to different human cancer
cell lines. In particular human breast, colon, gastric and bone cancer cell lines were also
able to sense and respond to change in elastic modulus through the change in the rate of
tumorigenicity. The optimized modulus for regulating tumorigenic capacity of cancer
cells was markedly different for different cell lines and it was found that at certain
modulus the proliferation capacity of cancer cells can be completely diminished.
Compared to conventional in vitro methods of culturing tumor spheroids in low-adhesion
plates, the PEGDA engineered matrix increased the tumorigenicity (density and number
of tumorspheres) and maintained CSCs properties for longer time periods. This could be
reasonably attributed to the suitable structure and mechanical properties of the matrix.
Consequently the encapsulated cells mimic the actual tissue mechanobiology and
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increase the possibility of EMT or similar biological events.
Our understanding of CSC maintenance mechanisms remains limited due to numerous
uncertainties in the transduction pathways of CSCs [3]. This synthetic micro-engineered
matrix can be used as a tool to improve the cellular interaction level and optimize
temporal condition of microenvironment maintaining stem cells properties in vitro and
studying the regulatory effect of specific proteins in biological pathways on CSC
maintenance without interference of other factors.
3.3 EFFECT OF CELL-BINDING PEPTIDES IN CSCS MAINTANANCE
3.3.1 CD44 BINDING PEPTIDE CONJUGATED TO PEGDA INERT MATRIX
ON MAINTENANCE OF 4T1 BREAST CANCER STEM CELLS AND
TUMORSPHERE FORMATION
We have shown shat tumorsphere formation in the PEGDA gel depended strongly on the
gel modulus [123]. Both 4T1 mouse and MCF7 human breast carcinoma cells formed
spheres in the gel with 5 kPa modulus, and the sphere formation was correlated with the
expression of CSC markers [123]. To determine whether non-cancerous cells could form
spheres in the PEGDA gel, MCF10a normal human breast epithelial cells were
encapsulated in the gel with 5 kPa modulus and sphere formation was compared with
those of 4T1 and MCF7 breast cancer cells. Fluorescent images a-c in Figure 3.15 show
that 4T1 and MCF7 cancer cells encapsulated in the gel formed spheres but not the
normal MCF10a cells, suggesting that the spheres originated from the CSC subpopulation of 4T1 and MCF7 cancer cells.The cell number density, sphere size, and size
distribution for 4T1, MCF7 and MCF10a cells encapsulated in the gel after 6 and 9 days
incubation in stem cell culture medium are shown in Figures 1d-1f. The cell density of
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4T1 and MCF7 cells significantly increased for both time points, while that of MCF10a
remained at a low level (Figure 3.15 d), suggesting that the PEGDA gel promoted the
proliferation of tumor cells, but not the normal cells. The density of 4T1 tumorspheres
was slightly higher than that of MCF7 after 6 or 9 days of incubation. 4T1 cells also
formed larger spheres than MCF7 as shown in Figure 3.15 e. After 9 days of culturing in
the gel, nearly 40% of the 4T1 spheres were larger than 80 µm while most of the MCF7
spheres were between 40 and 80 µm (Figure 3.15 f). MCF10a remained as single cells in
the gel with size smaller than 20 µm. The expressions of breast CSC markers CD44,
CD24, and ABCG2 for the encapsulated cells are shown in Figures 1g-1i. After 6 days of
incubation, CD44 expression level in 4T1 and MCF7 cells increased by 10 folds of the
initial level (Figure 3.15 g). CD44 expression was further increased in 4T1 cells 9 days
after encapsulation. However, as reported previously, the expression of CD44 in 4T1 and
MCF7 cells started to decrease after 11 days of incubation irrespective of the extent of
cell viability and the increase in tumorsphere size [123]. The expression of CD24 was
significantly reduced in 4T1 cells but increased slightly in MCF7 (Figure 3.15 h).
Although CD44+/CD24- cells are considered breast CSCs, the expression of CD24 as a
CSC marker in MCF7 is not conclusive. Previous studies have indicated that
CD44+/CD24- and CD44+/CD24+ cells both display CSC phenotypes in MCF7 cells
[92]. The discrepancy may be due to different primers used for real time PCR
quantification, and antibodies used for cell sorting as well as the methods used for
analysis. The expression of ABCG2, a subunit of ABC transporter that is responsible for
the drug resistance of CSCs was also increased in 4T1 and MCF7 cells (Figure 3.15 i).
On the other hand, the expression of these markers in MCF10a cells did not change.
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Figure 3.16 a-c shows representative images of live (green) and dead (red) 4T1 cells
encapsulated in PEGDA gels with 5 kPa modulus after 2 (a), 6 (b) and 12 (c) days,
respectively. The insets are the corresponding figures in the 70 kPa gel. For 5 kPa gel,
cell viability after 2, 6, and 12 days increased from 91±3% to 94±4% and 97±2%,
respectively. For the high modulus 70 kPa gel, no tumorsphere formed and cell viability
decreased from 89±4% at day 2 to 84±3% and 78±2% at days 6 and 12, respectively.
Based on these results, the effect of peptide conjugation on tumorsphere formation was
investigated with 4T1 cells in the PEGDA gel with 5kPa modulus and incubation time of
9 days.
The CD44+/CD24- marker expression is widely used for identification of breast CSCs.
Flow cytometry analysis of MCF7 cells isolated from the gel is shown in Figure 3.17.
The percentage of CD44+/CD24- cells before encapsulation in the gel was 2% (Figure
3.17 a) but it increased to 53% (Figure 3.17 b) and 76% (Figure 3.17 c) after 3 and 8 days
incubation in the gel, respectively. However, the percent CD44+/CD24- cells decreased
to 27% after 11 days incubation in the gel (Figure 3.17 d). These results are consistent
with our previous results in which the CD44 mRNA expression of 4T1 and MCF7 cells
initially increased with time, then began to decrease after 14 days of incubation in the gel
[123]. The flow cytometry results demonstrate that the percentage of CSCs in the
population of cells encapsulated in the gel increased dramatically after 8 days with
incubation time and tumorsphere formation. Since the percentage of live cells in the gel
increased with incubation times (see Figure 3.16), the decrease in the percentage of CSCs
at day 11 (Figure 3.17 d) was presumably due to the differentiation of CSCs.
It has been shown that CD44bp inhibits breast tumorsphere formation and maintenance of

56

CSCs in vitro[79]. The focus of this work was to test the effect of cell binding peptides
including CD44bp that interacts with the CD44 receptor up-regulated on CSCs,
conjugated to the PEGDA hydrogel on tumorsphere formation in 4T1 tumor cells.
Groups included the PEGDA gel without peptide conjugation (control, labeled as Ctrl in
Figure 3.18), the gel with CD44bp or scrambled CD44bp (s-CD44bp) dissolved in the gel
and in the culture medium to maintain constant peptide concentration (labeled as Dis),
and the gel with CD44bp or s-CD44bp conjugated to the gel (covalent attachment,
labeled as Conj). Fluorescent images a-d in Figure 3.17 show the tumorspheres formed in
conj CD44bp, conj s-CD44bp, dis CD44bp, and dis s-CD44bp, respectively.
Tumorsphere formation was abolished when 4T1 cells were encapsulated in the CD44bp
conjugated gel, indicating the importance of CD44 signaling in the maintenance of CSCs.
The effect of CD44bp was consistent with previous reports [79]. However, CD44bp
dissolved in the gel (images c and d) did not inhibit sphere formation. These results
suggested that CD44bp did not function as a soluble chemokine to inhibit CSC
proliferation but functioned within the insoluble part of the ECM. We also tested the
effect of a scrambled CD44bp (s-CD44bp). Conjugated or dissolved s-CD44bp had no
significant effect on tumorsphere formation, indicating that bioactivity was specific to
CD44bp. Figures 4e and f show the effect of CD44bp on cell number density and sphere
size of 4T1 cells encapsulated in the gel after 9 days of incubation. The 4T1 cell density
in the gel reached 14 x106/mL after 9 days with 1.4 x 105/mL initial cell seeding in the
gel. The density of 4T1 cells in the gel with CD44bp (conjugated or dissolved and with or
without mutation) were lower compared with the gel without any peptide. However, cells
in the conj CD44bp gel had the strongest effect on cell density and completely abolished
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Figure 3.15 Sphere formation and the effect of cell type encapsulated in PEGDA gel on the
expression of CSC markers. Representative fluorescent images of the tumorsphere size and
distribution for 4T1 (a), MCF7 (b), and MCF10a (c) cells encapsulated in PEGDA gels (1.46105
cells/ml), and cultured in stem cell culture medium. Encapsulated cells were stained with
phalloidin for cytoskeleton (red) and DAPI for nucleus (blue). Effect of cell type on cell number
density (d) and tumorsphere diameter (e) for tumor cells encapsulated in PEGDA hydrogel and
incubated in stem cell culture medium for 6 or 9 days. The sphere size distribution (f) was
determined 9 days after encapsulation. Effect of cell type on CD44 (g), CD24 (h) and ABCG2 (i)
mRNA marker expression for tumor cells encapsulated in PEGDA hydrogel and incubated in
stem cell culture medium for 6 or 9 days. RNA levels of the cells were normalized to those at
time zero. A star indicates a statistically significant difference (p,0.05) between the test group and
the groups with different cell type in the same time point.

sphere formation (Figure 3.18 a). The expression of CSC markers, CD44, CD24, ABCG2
and SCA1 was also determined and the results are shown in Figures 4 g to j, respectively.
4T1 cells in the CD44bp gel that formed spheres (conj s-CD44bp, dis CD44bp and dis sCD44BP) had high expressions of CD44, ABCG2 and SCA1 and low expression of
CD24. On the other hand, cells in the conj CD44bp gel, which did not form
tumorspheres, had decreased expressions of CD44, ABCG2 and SCA1, and increased
expression of CD24. These results indicated that tumorsphere formation by 4T1 cells in
the gel correlated with the CSC population.
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Figure 3.16.Viability of the cells encapsulated in PEGDA gel. Representative images of live
(green) and dead (red) 4T1 cells encapsulated in PEGDA gels with 5 kPa modulus and cultured
in stem cell culture medium for 2 (a), 6 (b) and 12 (c) days. Cells were stained with cAM/EthD
for live (green) and dead (red) cell imaging. The insets in (a) to (c) are live/dead images of 4T1
cells in PEGDA gels with 70 kPa modulus after 2, 6, and 12 (day), respectively.

3.3.1.1 EFFECT OF CD44 BINDING PEPTIDE ON 4T1 TUMORFORMATION IN
VIVO
It is well established that tumor growth in vivo requires a permissive environment that
can support vascularization and matrix remodeling [124, 125]. Therefore, a degradable
version of PEGDA gel (dPEGDA) was used to investigate the effect of CD44bp
conjugated to the gel on tumor formation in vivo by the encapsulated 4T1 cells. Groups
included 4T1 tumorspheres injected directly without the gel, gels without cell, gels
without peptide conjugation but with 4T1 tumorspheres, and gels with 4T1 cells
conjugated with CD44bp. The gels without cell did not from a visible tumor after 4
weeks (Figure 3.19). Tumors became measurable after 10 days with direct subcutaneous
injection of 4T1 tumorspheres. 4T1 tumorspheres in the gel without CD44bp conjugation
also formed a tumor after 13 days of inoculation. Even though the formation of tumor
was delayed when cells were encapsulated in the gel, the growth rate (the slop of the
tumor size curve) did not differ significantly between the group with 4T1 in PBS and 4T1
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in the gel (Figure 3.19). The observed lag time in tumor formation for the encapsulated
cancer cells is presumably related to the degradation time of the gel and connection of the
tumor cells to the surrounding tissue [126]. However, 4T1 cells encapsulated in the conj
CD44bp gel did not form a visible tumor after 4 weeks of inoculation, indicating that
CD44bp conjugated to the gel inhibited tumor formation in vivo.

Figure 3.17 CSC population in the cells encapsulated in PEGDA gel. MCF7 cells were
encapsulated in PEGDA gels with 5 kPa modulus and cultured in stem cell culture medium. Cells
before encapsulation (a), 3 days (b), 8 days (c) and 11 days (d) after encapsulation were stained
with CD442FITC and CD24-PE antibodies. The population of CD24+, CD44+ and
CD44+/CD242 cells was determined by flow cytometry. Flow cytometrywas repeated multiple
times on each sample to ascertain reproducibility of the result
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Figure 3.18 .Effect of CD44bp on tumorsphere formation and CSC marker
expression.Representative fluorescent images of the tumorsphere size and distribution for 4T1
cells encapsulated in PEGDA gels (1.46105 cells/ml) conjugated with CD44bp (a, conj CD44bp),
conjugated with a scrambled sequence of CD44bp (b, conj s-CD44bp), CD44bp dissolved in the
gel (c, dis CD44bp), and s-CD44bp dissolved in the gel (d, dis s-CD44bp) and cultured in the
stem cell culture medium for 9 days. Effect of CD44bp on cell number density (e) and
tumorsphere number density (f) for 4T1 tumor cells encapsulated in PEGDA hydrogel and
incubated in the stem cell culture medium for 9 days. Effect of CD44bp conjugation on CD44 (g),
CD24 (h), ABCG2 (i) and SCA1 (j) mRNA marker expression for 4T1 tumor cells encapsulated
in PEGDA gel and incubated in the stem cell culture medium for 9 days. RNA levels of the cells
were normalized to those at time zero. A star indicates a statistically significant difference
(p,0.05) between the test group and ‘‘Ctrl’’.
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3.3.2 COMPARING THE EFFECT OF CD44 BINDING PEPTIDE ON
TUMORSPHERE FORMATION OF 4T1 CELLS WITH INTEGRIN AND
HEPARIN BINDING PEPTIDES
The effect of CD44bp on tumorsphere formation in the gel prompted us to test other cellbinding peptides. Ibp, an integrin receptor binding peptide and FHbp, a heparin-binding
domain of fibronectin that binds to cell surface heparin sulfate proteoglycans, were
conjugated to the gel. Groups included 4T1 cell seeded gel without peptide conjugation,
the cell-seeded gel with CD44bp conjugation, the cell-seeded gel with Ibp conjugation,
and the cell-seeded gel with FHbp conjugation. For determination of marker expression,
gels conjugated with a scrambled sequence of the peptides were also tested. Fluorescent
images a-d in Figure 3.20 show sphere formation by 4T1 cells in the gels without peptide,
with conj CD44bp, conj Ibp, and conj FHbp, respectively. The Ibp conjugation, similar to
CD44bp, abolished 4T1 tumorsphere formation in the gel (Figure 3.20 c). However,
tumorsphere formation increased when 4T1 cells were encapsulated in the FHbp
conjugated gel (Figure 3.20 d). Further characterization of the cells in these gels (see
Figures 6 e-g) showed that the cells in Ibp and CD44bp conjugated gels had reduced cell
number, did not form sphere, and remained as single cells or small cell aggregates (<25
µm). On the other hand, the cells in FHbp conjugated gel had higher cell number and
larger spheres compared with those in the gels without peptide conjugation.
To determine whether the size and number density of tumorspheres in the gel correlated
with the CSC sub-population, CD44 and CD24 expression of the cells in the peptideconjugated gels were measured. 4T1 cells in the gels without any peptide conjugation and
with FHbp conjugation had elevated expression of CD44 marker while the cells in gels

62

conjugated with CD44bp or Ibp had decreased CD44 expression (see Figure 3.20 h).
More importantly, the CD44 expression in the cells encapsulated in FHbp conjugated gel
was significantly higher than that without peptide conjugation. The expression of CD24
in those gels had an opposite pattern to that of CD44 (see Figure 3.20 i). In breast cancer,
the expression of epidermal growth factor receptor (EGFR) is also closely related to the
maintenance of CSCs [119, 127]. The expression of EGFR marker by 4T1 cells
encapsulated in the peptide-conjugated gels is shown in Figure 3.20 j. Similar to CD44
marker, the expression of EGFR was increased in the cells encapsulated in FHbp
conjugated gel but decreased in CD44bp and Ibp conjugated gels. Furthermore,
conjugation of a mutant sequence of the peptides to the gel had insignificant or limited
effect on tumorsphere formation and the expression of CSC markers, compared to the
wild type (see Figures 3.20 h-j).
The effect of cell binding peptides on CSC sub-population was further examined in 4T1
cells by flow cytometry. The percentage of CD44+/CD24- cells in 4T1 cells cultured
without gel encapsulation was about 6% (Figure 3.21 a). This percentage doubled to
12% for cells encapsulated in the PEGDA gel without peptide conjugation (Figure 3.21
b). When 4T1 cells were encapsulated in the gel conjugated with FHbp, the subpopulation of CD44+/CD24- cells was further increased to about 21% (Figure 3.21 c).
Conversely, the fraction of CSC sub-population in the gel decreased to the original level
(5.4% for Ibp and 6.5% for CD44 bp) when 4T1 cells were encapsulated in the gels
conjugated with Ibp (Figure 3.21 d) or CD44bp (Figure 3.21 e) that inhibited sphere
formation. These results suggested that tumorsphere formation by 4T1 cells in the gel
was related to the CSC sub-population.
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Figure 3.19 Effect of CD44bp conjugated to the gel on tumor formation in vivo. The gel
without cell (negative control, light blue), 4T1 tumospheres in suspension (positive control,
red), 4T1 cells encapsulated in the gel without CD44bp (green), and 4T1 cells encapsulated in
the gel with CD44bp (light blue) were inoculated subcutaneously in syngeneic Balb/C mice.
Tumor sizes were measured daily from post-inoculation day 11 (n = 6/group). Tumor growth
was not observed in the negative control group (the gel without cell) and the group with 4T1
cells in the gel with CD44bp (the lines for these two groups are overlapped in the figure).

3.3.3 EFFECTS OF CELL BINDING PEPTIDES ON THE EXPRESSION OF
OTHER CSC RELATED MARKERS
One of the pathways to transform differentiated cancer cells into CSCs is epithelial to
mesenchymal transition (EMT) [115, 116]. The hallmark of EMT is the decreased
expression of E-Cadherin and increased expression of N-Cadherin [128, 129]. The
expressions of E-Cadherin and N-Cadherin 3 and 9 days after cells were encapsulated in
the peptide-conjugated gels are shown in Figures 8 a and b, respectively. At the early
time point (3 days), the expression of E-Cadherin was decreased while the expression of
N-Cadherin was increased in the gel with FHbp, suggesting that EMT was a possible
mechanism for the enhanced tumorsphere formation
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Figure 3.20 Comparison of tumorsphere formation in PEGDA gels conjugated with
CD44bp, Ibp, or FHbp. Representative fluorescent images of the tumorsphere size and
distribution for 4T1 cells encapsulated in PEGDA gels (1.46105 cells/ml) without peptide
conjugation (a), conjugation with CD44bp (CD44bp, b), conjugation with RGD integrin-binding
peptide (Ibp, c) and conjugation with fibronectin-derived binding peptide (FHbp, d) and cultured
in the stem cell culture medium for 9 days. Effect of cell binding peptide on cell number density
(e), tumorsphere number density (f) and sphere size distribution (g) for 4T1 tumor cells
encapsulated in PEGDA gel and incubated in the stem cell culture medium for 9 days. Effect of
cell binding peptide on CD44 (h), CD24 (i) and EGFR (j) mRNA marker expression for 4T1
tumor cells encapsulated in PEGDA hydrogel and incubated in the stem cell culture medium for 9
days. RNA levels of the cells were normalized to those at time zero.
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Figure 3.21 CSC population in cells encapsulated in PEGDA gel conjugated with
CD44bp, Ibp, or FHbp. 4T1 cells were encapsulated in PEGDA gels with 5 kPa modulus
and cultured in stem cell culture medium. Cells before encapsulation (a), 9 days after
encapsulation in the gel without peptide (b), 9 days in the gel conjugated with FHbp (c), 9
days in the gel conjugated with Ibp (d), and 9 days in the gel conjugated with CD44bp were
stained with CD44-FITC and CD24-PE antibodies. The population of CD24+, CD44+ and
CD44+/CD242 cells was determined by flow cytometry. Flow cytometrywas repeated
multiple times on each sample to ascertain reproducibility of the results.

in the gel. However, at the later time point (9 days), the expression of E-Cadherin in the
cells grown in FHbp gel was much higher than that in other groups. This was probably
due to sphere formation in the FHbp gel. E-Cadherin is a cell adhesion protein and its
expression increases with increased cell-cell interaction [130]. Consistent with that, cells
in the Ibp and CD44bp gels, which did not form spheres, had low expressions of ECadherin (see Figure 3.22 b).
The importance of integrins in cancer and CSC maintenance is well known [131]. Since
RGD is an integrin binding peptide, we examined the expression of integrin αV and β3,
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two integrin subunits required for RGD binding, and the expressions are shown in
Figures 3.21 c, d, respectively.

Figure3.22 Expression of the markers related to CSC maintenance in cells grown in the
gel conjugated with CD44bp, Ibp, or FHbp. Effect of cell binding peptide on N-Cadherin
(a), E-Cadherin, (b), integrin aV (c), and integrin b3 (D) mRNA marker expression for
4T1 tumor cells encapsulated in PEGDA hydrogel and incubated in the stem cell culture
medium for 9 days. Effect of cell binding peptide on vimentin (e) and VEGF (f) protein
expression. The protein expression was determined by western blot and quantified with imageJ.
Actin was used as the internal control and the protein expressions were normalized to those at
time zero. RNA levels of the cells were normalized to those at time zero.
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The expression of integrin αV and β3 was reduced in cells grown in FHbp and CD44bp
gels, even though the cells in FHbp gel formed spheres while those in CD44bp gel did
not. Interestingly, the expression of integrin αV and β3was significantly increased in the
cells in Ibp gel. It is possible that blocking integrin signaling by RGD activates a
feedback loop to induce integrin expression. These results suggest that the expression of
integrin does not correlate directly with tumorsphere formation or CSC maintenance of
4T1 cells. Conjugation of a mutant sequence of the peptides to the gel had limited effect
on the expression of CSC markers, indicating that the effect was specific to the wild type.
The expression of vimentin[132] and VEGF, two other markers related to invasive breast
cancer and CSC maintenance [133], was also determined at the protein level, as shown in
Figure 3.22 e, f. The expression of vimentin and VEGF was high in cells that formed
spheres, and their expression correlated with the sphere size and number (Figure 3.20 e,
f).
3.3.4 EFFECT OF CD44 BINDING PEPTIDE CONJUGATED TO AN
ENGINEERED INERT MATRIX ON MAINTENANCE OF HUMAN CANCER
STEM CELLS
We have shown that conjugating CD44 binding peptide to the PEG engineered matrix
abolished tumorspheres formation by the encapsulated 4T1 breast cancer cells in the
optimum modulus of 5kPa whereas CD44bp dissolved in the gel did not have any
specific inhibitory effect on spheroid formation [27]. These results suggested the
functionality of CD44bp as an insoluble part of ECM not a soluble chemokine.
Here, we investigate the effect of CD44bp conjugated to the PEGDA hydrogel on the
maintenance of breast, colon and, bone CSCs in their optimum reported moduli of 5, 25
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and 50 kPa and compare this effect to scrambled sequence of the peptide as a control.
Fluorescent images in Figure 3.21 show the evolution of tumorsphere for these cell lines
in the presence of mutant CD44bp (Row 1) and CD44bp (Row 2). Columns 1, 2 and 3
correspond to tumorsphere distribution for MDA-MB-231, HCT116 and U-2 OS cells
encapsulated in PEGDA gel with elastic modulus of 5, 25 and 50 kPa respectively after 9
days of encapsulation. Images B, D and F in Figure 3.21 show that conjugated CD44bp
completely inhibited tumorsphere formation in MDA-MB-231, HCT116 and U-2 OS cell
lines respectively. This highlights the importance of CD44 signaling in the maintenance
of CSCs for these cell lines. Yeung et al. reported that CD44 can be used as a marker to
enrich for CSCs from primary colorectal tumor tissue and clearly identify CSCs in
colorectal cancer-derived cell lines [28]. It has also been shown in another study that
CD44 protein plays an important role in colorectal tumor progression and metastasis in
humans [29]. Several clinical studies suggested that CD44 expression correlates with
bone metastasis by enhancing tumorigenicity and downregulation of this marker
markedly suppressed tumorigenicity and bone metastases in nude mice [16, 30, 31].
However, mutant CD44bp conjugated to the gel (images A, C and E) was not able to stop
sphere formation suggesting that bioactivity is specific to CD44bp. The effect of CD44bp
on cell number density, spheres size and density of MDA-MB-231, HCT116 and U-2 OS
cells in the gel are shown in Figures 7 G, H and I, respectively. After 9 days of
incubation, The MDA cell count of viable cells in the control (ctrl) group of the gel
without any peptide reached 1.4 (106/ml) cells where the density of MDA cells in the gel
with conjugated peptide (CD44bp) was about half of the initial number density of 0.6
(106/ml) and did not show any growth potential.
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Although cells number density in the group of mutant peptide (mCD44bp) was lower
than control group without peptide but it was significantly higher than the number of cells
in CD44bp group. Similar behavior was observed in the control and mutant peptide
groups of colon and bone cancer cells after 9 days. A significant change in number
density and sphere formation of both groups was observed while they showed
approximately same level of low number density in the CD44bp group with no spheroid
formation (fig 3.1G). The number density of cells in control group and mutant peptide of
colon and bone cancer cell lines is lower than MDA cells which can be related to level of
malignancy and potential in sphereformation for each cell line. As we showed in our
previous study, MDA a highly malignant breast cancer cell line shows higher potential of
spheroid formation compared to HCT116 and U-2 OS with lower levels of malignancy.
The effect of CD44bp on average tumorsphere size and density after 9 days of
encapsulation is shown in Figure 3.21 H, I for three cell lines. The average tumorsphere
diameter in control groups of MDA, HCT116 and U-2 OS cell lines increased from
approximate 10 m at day zero to the range of 50, 30 and 30 m respectively in 9 days
where average diameter for the group with CD44bp without any spheres remained in the
size range of single cells and aggregates (< 20 m). The number density of spheroids in
control group and mutant peptide of MDA cell lines reached as high as 6 (103/ml) after 9
days while it was in the range of 1.5 (103/ml) and 2.5 (103/ml) for colon and bone cancer
cell lines respectively. The number of spheroids in CD44bp group with single cells and
no spheres reported zero.
The effect of CD44bp on the expression of CSCs markers for each cell line is reported in
Figure 3.23 J, K and L. Figure 3.23 J shows the expression of CD44 and EGFR, the well-
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Figure 3.23 Effect of CD44 binding peptide on tumorsphere formation by human tumor cell
lines
Columns 1,2 and 3 correspond to tumorsphere distribution for MDA-MB-231, HCT116 and U-2
OS cell lines encapsulated in PEGDA gel with elastic modulus of 5, 25, 50 kPa respectively. Row
1 and 2 correspond to the gels modified with mutant CD44 binding peptide as a control and CD44
binding peptide respectively after 9 days of incubation. Cells were stained with Phalloidin for
cytoskeleton (red) and DAPI for nucleus (blue), and imaged with an inverted fluorescent
microscope. (G) Cells density (H) Average tumorsphere size (I) Tumorspheres number density (J,K,L)
mRNA expression levels of different markers for MDA-MB-231, HCT116 and U-2 OS cell lines
encapsulated in PEGDA gel with elastic modulus of 5, 25, 50 kPa respectively. Groups were gels modified
with CD44 binding peptide, gels modified with mutant CD44 binding peptide and gels without peptide as a
control, for each cell line.
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studied markers in human breast CSCs for MDA cells, after 9 days. Cells in the gel with
no peptide and mutant peptide groups indicated about 60 and 50 fold increase in
expression of CD44 marker respectively whereas the fold expression of this marker for
cells with CD44bp was lower than one. Similarly, while the fold expression of EGFR for
CD44bp did not change significantly, control and mutant peptide were highly expressed
for this marker. Expression of CD44 and TGFβ for colon CSCs has been shown in Figure
3.23 K. For control and mutant peptide groups cells reached more than 40, 35 times in
CD44 fold expression respectively, and approximately 15 times of TGFβ fold increase.
Expression of CD44 was lower than one for peptide group. Similarly, CD44 and CD133
in bone cancer cells expressed more than 30 fold for control and mutant peptide groups
and lower than one for CD44bp. These results demonstrate that CSCs markers expression
by MDA, HCT116 and U-2 OS cells in the gel correlates with the ability of tumorsphere
formation. The slight difference in results of mutant CD44bp compared to ctrl group can
be explained by the non-specific binding of mutant peptide to the corresponding receptors
with much lower affinity.
It has been reported in several studies that down-regulation of CD44 by different
therapeutic agents leads to tumor suppression. For example, targeting CD44 with antiCD44 monoclonal antibodies (H90, A3D8, HI44a) reversed differentiation blockage of
leukemic cell lines, and in some cases, inhibit proliferation and stimulated apoptosis [32].
Mandal et al. showed in two different studies that down-regulation of CD44 marker in
metastatic breast cancer cells correlated with inhibitory effects of simvastain and fish oil
on bone metastasis [33, 34]. In another study, a CD44 binding peptide, A6 peptide,
inhibited melanoma cancer cell migration and metastasis in vivo [35].
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In current study, using CD44bp inhibited breast, colon and bone tumorsphere formation
in vitro.
These results are in agreement with previous studies on this peptide that Hibino et al.
reported inhibition of tumor metastasis and growth as well as increased apoptosis in B16F10 melanoma cells by A5G27 peptide [22]. Hibino et al. also explained the potential
mechanism of A5G27 inhibitory effect on WiDr human colorectal carcinoma cells. They
have shown that A5G27 inhibits metastasis and angiogenesis by blocking FGF2 binding
to the heparan sulfate side chains of CD44. This adhesion blocked cells binding to
fibroblast growth factor (FGF2) and inhibited regulation of FGF2 signaling including
tyrosine phosphorylation [36].
3.3.5 COMPARING THE EFFECT OF CD44 BINDING PEPTIDE ON
TUMORSPHERE FORMATION BY HUMAN CANCER CELL LINES WITH
INTEGRIN AND HEPARIN BINDING PEPTIDES
Integrin family of proteins is mainly responsible for ECM signaling and tumor
progression in different types of cancer including breast cancer [37, 38]. These cell
surface receptors with important role in cellular matrix interactions involves in cancer
cell adhesion, growth, migration
and invasion [37, 39]. For example, ovarian cancer cell lines showed significantly high
expression of multiple subunits of integrins mediating proliferation, adhesion, migration
and invasion of cancer cells in response to ECM. Blocking antibodies against these
integrin subunits inhibited tumor progression in these cell lines [39]. Birnie et al. reported
the importance of integrins interaction with ECM in human prostate cancer stem cells
maintenance [40].
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One of the main subunits of integrin receptor is αVβ3 and it has been associated with the
pathogenesis of several types of cancer. Monferran et al. have shown that downregulation of αVβ3 integrin increased glioma cancer cells response to radiotherapy [27].
In another study, inhibition of αVβ3 integrin blocked the CSC driven tumor formation in
a prostate xenograft model [41]. Therefore, finding therapeutic agents to target integrins
can be a promising method to reduce tumor progression in vivo.
Effect of heparin and integrin binding peptides on tumorsphere formation by breast
cancer cells including MDA is shown in Figure 3.24. MCF10a, a normal human breast
epithelial cells, MCF7, human breast cancer cell line with moderate malignancy, MDA
(human) and 4T1 (mouse) highly malignant breast cancer cells were encapsulated in the
gel with optimum modulus of 5 kPa and were used to study the effect of cell-binding
peptides on breast cancer cells with different levels of malignancy.
Fluorescent images A–F in Figure 3.24 indicate tumorsphere distribution for MDA-MB231, MCF7 and 4T1 cell lines encapsulated in PEGDA gel after 9 days of incubation in
rows 1, 2 and 3 respectively. Column 1 and 2 correspond to the gels modified with
FC/HV peptide and RGD peptide respectively. The RGD peptide, similar to CD44BP,
abolished tumorsphere formation in MDA, MCF7 and 4T1 cells in the gel (Figure 3.24 B,
D, F). It has been shown that RGD peptide as a well-known ligand of αVβ integrin
receptor hinders integrin-mediated signaling pathways in tumor progression [6]. Yu et al.
reported in a recent study that RGD peptide can cause clustering of integrin receptors
when cells are seeded on RGD peptide conjugated lipid membrane.
This clustering stimulates local actin polymerization and leads to cytoskeleton
remodeling [42]. This integrin-blocking peptide prevents integrin from regular

74

Figure 3.24 .Effect of heparin and integrin binding peptides on tumorsphere formation by
human breast tumor cell lines
Rows 1,2 and 3 correspond to tumorsphere distribution for MDA-MB-231, MCF7 and 4T1 cell
lines respectively, encapsulated in PEGDA gel with elastic modulus of 5 kPa after 9 days of
incubation.. Column 1 and 2 correspond to the gels modified with FC/HV peptide and RGD
peptide respectively. Cells were stained with Phalloidin for cytoskeleton (red) and DAPI for
nucleus (blue), and imaged with an inverted fluorescent microscope. (I) cells density (J) average
tumorsphere size, (K) tumorspheres number density and (L, M) mRNA expression levels of
different markers for MDA-MB-231, MCF7 and 4T1 breast cancer cell lines respectively,
encapsulated in PEGDA gel with elastic modulus of 5 kPa. (N) effect of Ibps and Hbps on tumor
formation in vivo.
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conformational shift necessary for transducing signals both inside and outside of the cells
and does not let cells sense matrix rigidity. Due to our previous study tumorsphere
formation in PEGDA hydrogel is rigidity dependent and this clustering prevents cells
from spheroid formation.
The ability of sphere formation increased when cells were encapsulated in the FC/HV
conjugated gel (Figure 3.24 A, C, E). The effect of all peptides on cell number density,
average sphere diameter and sphere number density after 9 days is shown in Figure 3.24
I, J, K. While MCF10a cells did not change significantly for cell count, sphere diameter
or density after 9 days, MCF7, MDA and 4T1 cells showed an increasing trend for all.
The highest cell count was observed for the group with H1 peptide. The control, H2 and
H3 groups were in next orders of growth potency respectively in all cell lines. This
suggests the stimulating effect of these peptide on sphere formation and cells growth. The
ability of these ECM-derived peptides to promote cell attachment and proliferation is
reported in different studies [43-48]. It was shown that Heparin Sulfate Proteoglycans
(HSPGs) present on the surface of tumor cells are important surface receptors for ECM
components [44, 49]. The key role of HSPGs in biological activities including
tumorigenesishas been shown in different studies [50-53]. It has been suggested that
HSPGs in cooperation with integrins such as αVβ3 integrin or independently create
signals for cell spreading and activation of adhesion plaques [50, 54-57]. The interacting
peptides with HSPGs activates the focal adhesion kinase (FAK), a mediator of cellextracellular matrix signaling pathways that is over-expressed in tumor cells and has been
shown to play a main role in in promoting breast cancer invasion and metastasis [58, 59].
It has been reported that even in the absence of cell attachment, FAK is required as a
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survival signal in breast tumor cells [60].
As shown in Figure 3.22 I, the number density of cells sharply decreased for Ibps that cell
count remained in the same order of initial day of encapsulation. The effect of cell
binding peptides on the average diameter of spheres in Figure 3.22 J confirms the highest
potential in spheroids growth for H1 peptide where control, H2 and H3 peptides were in
the next order respectively. Cells in the groups with Ibps did not form sphere and
remained as single cells or small cell aggregates (<25 µm). Similarly, cells in H1 group
showed the highest number densities of spheres about 6, 5 and 2 (103/ml) for 4T1, MDA
and MCF7 cells respectively. While cells in the groups with conjugated Ibps did not form
any spheres, the control, H2 and H3 showed secondary potential of spheroid formation
for all cell lines except the MCF10a which did not show any sensitivity to the peptides.
To determine whether the size and number density of tumorspheres in the gel correlated
with the CSC sub-population, the expression of CD44 and ABCG2 for the control and
peptide-conjugated gels was measured. ABCG2, an ATP- Binding Cassette involves in
efflux of chemotherapeutic agents and has been used to identify the presence of CSCs in
breast tumours[61-63]. Cells in the gels with H1 conjugated peptide and control group
had the highest fold expression of CD44 and ABCG2 markers for all cancer cell lines
respectively. The elevated expression of CD44 marker was also observed in H2 and H3
groups. Cells in gels conjugated with Ibps showed a sharp decrease in CD44 and ABCG2
marker expression after 9 days of encapsulation compared to Hbps (Figure 3.24 L, M).
The effect of heparin and integrin binding peptides conjugated to the gel on tumor
formation of encapsulated 4T1 cells has been investigatedin vivo by implanting grown
tumorspheroids encapsulated in a degradable version of PEGDA gel (dPEGDA) in mice.
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After 4 weeks, the highest average volume of tumors was observed in group with H1
peptide with a size more than 800 mm3. Measurable tumors also observed in Control, H2
and H3 groups with approximate sizes of 400, 250 and 200 mm3 respectively. 4T1 cells
encapsulated in the gel with conjugated Ibps did not form a visible tumor after 4 weeks of
implantation, suggesting that these peptides in conjugated form are able to inhibit the
tumor formation in vivo.
The inhibitory effect of I3 peptide on tumor growth, angiogenesis and metastasis has
been shown in several studies. In vivo, this peptide inhibited lung and bone metastases by
human melanoma cells in nude mice [64]. In another study, conjugation of I3 to
polyethylene glycol has improved anti-metastatic activity due to a longer half-life in
blood [65]. Two different studies reported that a repeating sequence of I3 peptide
inhibited the metastatic formation in the lung of malignant tumor cells more effectively
than I3 monomer [66] and the multi-meric I3 peptides showed enhanced activity in
inhibiting tumor growth and metastasis compared to the monomer [67]. I3 also blocks
angiogenesis i.e., in the presence of this peptide, tumors grew in the smaller size in vivo
by reduced numbers of blood vessels [68]. The mechanism by which I3 peptide acts is
not clear. Previous studies explained different possible mechanism for this antitumor
behavior. For example, it has been reported that I3 peptide bound to the 32/67 kD cell
surface receptor increased tyrosine phosphorylation [69]. In another study, Kim et al.,
reported that the presence of I3 polypeptide caused apoptosis in human fibrosarcoma
cells while scrambled sequence did not induce apoptosis [70]. Finally, It has been shown
that the inhibitory effect of I3 peptide on the growth and migration of human prostate
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cancer cells in vitro associates with inhibited ATP synthesis and increased caspase-9
activity [71].
Unlike I3, I2 has been mainly known for increasing angiogenesis and metastasis in vivo
[68]. It has been shown that intravenous injection of this peptide via the tail vein with
B16F10 melanoma cells caused an increase in the number of colonies on the surface of
the lungs [72]. It was reported that interactions of colon cancer cells with this peptide
caused the formation of metastatic foci and promoted metastasis to liver [73]. The
mechanism of action of this peptide is not defined but the ability of I1 in promoting
tumor growth and metastasis could be its key role in promoting angiogenesis [37, 74].
The other potential mechanism is enhanced protease activity based on previous studies
[68]. In this study we show that the stimulating effect of I1 peptide on encapsulated
cancer cells is dose dependent [37, 74] and 2 wt% concentration of this peptide
conjugated to the gel hinders spheroid formation. Higher than 1% of this peptide may
cause the conformational changes in the a3β1 and a6β1 integrins which are important
receptros in tumorigenesis and are suggested as receptors of IKVAV peptide [68]. This
results in spheroid formation abolition. Besides, the possible mechanism involving
protease enhancement and angiogenic activity of this peptide may change cells function
and activate different signaling pathway, which lead to abolition of tumorspheres.
The concept of CSC niche is based on the evidence that both normal stem cells and CSCs
utilize similar signaling pathways within a unique microenvironment to maintain
stemness. Signaling pathways that have been identified within the stem cell niche include
Notch, Hedgehog, PI3K, Wnt, STAT and TGF-β [134]. Processes such as inflammation,
EMT, hypoxia and angiogenesis within the microenvironment regulate those pathways to
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sustain the rare population of CSCs [115]. The cell microenvironment is composed of
many cellular and non-cellular components
such as cell binding proteins, growth factors, and nutrients. In addition, cells also respond
to mechanical properties of the microenvironment such as stiffness and porosity of the
ECM [135]. Therefore, cell fate is determined by the specific combination of signals
presented in its microenvironment. Due to the complex biochemical composition of the
niche, it is difficult to study the role of individual factors in cell behavior with in vitro
models. We have developed an inert hydrogel as a 3D matrix that supports the
proliferation and maintenance of breast CSCs in a certain range of elastic moduli without
the interference of proteins, peptides, and other biomolecules in the ECM. In this study,
we investigated the effect of conjugating cell-binding peptides to the inert gel with
controlled stiffness on the maintenance of stemness of breast CSCs without the
interference of other factors.
CD44 is the most widely used marker to identify breast CSCs. CD44 is a cell surface
proteoglycan that functions in cell-cell and cell-matrix adhesion. It binds to many ECM
ligands including hyaluronic acid (HA), osteopontin, fibronectin and collagen [136-139].
It also binds to matrix metalloproteinases (MMPs) and growth factors to promote tumor
invasion and growth [11, 12]. Therefore, CD44 utilizes many signaling pathways to
regulate cell behavior, and its activity depends on conformational changes and posttranslational modifications after ligand binding. CD44bp is a peptide derived from the Ddomain of laminin α5 chain [79]. It binds to CD44 and inhibits lung colonization of tumor
cells in vivo but does not inhibit tumor cell proliferation when added to the culture
medium [79]. In this study, we found that CD44bp inhibits tumorsphere formation only
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when conjugated (covalently attached) to the gel. Dissolving the peptide in the gel or in
the medium did not have an effect on tumorsphere formation. This result suggests that
CD44bp does not act as a soluble chemokine to block or activate CD44 signaling. We
speculate that CD44bp induces a conformational change in CD44 receptor through a
mechanism like receptor clustering. In previous studies, another CD44 binding peptide,
A6, was found to enhance cell adhesion to HA and induce FAK and MEK
phosphorylation in a CD44 dependent manner in breast and ovarian cancer cells [140].
A6 also inhibited cancer cell migration and metastasis in vivo[140]. It is unclear whether
CD44bp binding also causes phosphorylation of these kinases in a CD44 dependent
manner.
ECM signaling mainly occurs through the integrin family of proteins [141]. The main
integrin receptor is αVβ3 and it has been implicated in the pathogenesis of several types of
cancer. Down-regulation of αVβ3 integrin sensitized cancer cells to radiotherapy [142].
Inhibition of αVβ3 integrin blocked the CSC driven tumor formation in a prostate
xenograft model [143]. Further studies suggest that blocking αVβ3 integrin leads to
redistribution of β-catenin from the nucleus to the cytoplasm [80]. Nuclear localization of
β-catenin is known to be one of the mechanisms for maintaining stemness. Therefore,
αVβ3 integrin-mediated signaling is required for the maintenance of CSCs. RGD peptide,
a well-known ligand of αVβ3 integrin receptor, blocks the integrin mediated cell adhesion.
In this study, RGD peptide (Ibp) without conjugation to the hydrogel did not affect
tumorsphere formation. Since the PEGDA hydrogel did not have cell-binding motifs,
blocking cell adhesion sites by RGD might not have a significant effect. However, the
matrix rigidity is sensed by the actin cytoskeleton through integrin receptors [144-146].
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A recent study showed that membrane-bound RGD can induce the clustering of integrin
receptors when cells are seeded on RGD peptide conjugated lipid membranes [147].
Furthermore, integrin receptor clustering stimulates local actin polymerization and leads
to cytoskeleton remodeling [147]. We speculate that RGD peptide conjugated to the
PEGDA hydrogel causes clustering of the integrin receptors, which in turn, alters cells’
ability to sense matrix rigidity. Since tumorsphere formation in PEGDA hydrogel is
rigidity dependent, it would be interesting to determine whether breast cancer cells can
form spheres in the RGD conjugated PEGDA hydrogel under a different elastic modulus.
The RGD integrin binding peptide is present in many ECM components, but there are
other binding motifs in the ECM. For example, fibronectin has a RGD-independent
heparin-binding domain in the C-terminus that binds to heparin sulfate proteoglycans on
the surface of tumor cells [81, 148]. In this study, we found that unlike CD44 and RGD
binding peptides, FHbp conjugated to the gel enhanced tumorsphere formation. It has
been shown that FHbp promotes focal adhesion formation in culture cells [81] and it
likely activates the focal adhesion kinase (FAK). Several lines of evidence have indicated
the role of FAK in promoting breast cancer invasion and metastasis [149, 150] and FAK
is required for the survival of breast cancer cells in the absence of cell attachment. The
expression of FAK dominant negative mutant in breast cancer cells leads to deactivation
and degradation of endogenous FAK and cell apoptosis without matrix attachment [151].
Therefore, FHbp, unlike CD44bp and Ibp that block the receptor signaling, may activate
FAK and promote CSC survival. As a result, 4T1 cells encapsulated in the gel conjugated
with FHbp formed larger and greater number of spheres.
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Fibronectin is a mesenchymal marker and its expression is increased during the process
of EMT. In the EMT process, certain epithelial cells loose cell-cell adhesion and invade
the local tissue. It is thought that a similar transformation occurs during cancer metastasis
[152]. Recent studies have shown that EMT induction is sufficient to turn differentiated
cancer cells into CSCs [115, 116]. A recent study showed that mammary tumor cells
displayed a more differentiated phenotype when cultured on collagen coated substrates,
while they displayed an invasive phenotype and EMT-related gene expression pattern
when cultured on fibronectin coated substrates [153]. Therefore, FHbp may induce EMT
which in turn enhances tumorsphere formation. In the EMT process, the expression of ECadherin is down regulated but E-Cadherin may also be up-regulated with increasing
cell-cell interaction. Consistent with this, the expression of E-Cadherin was initially
reduced in our study in the cells encapsulated in FHbp gel but increased at a later time
point. The expression pattern of some of the examined EMT markers also suggests that
enhanced EMT may contribute to the increased tumorsphere formation in FHbp
conjugated gels.
This study also included the mutant forms of the peptides. Although the mutants did not
affect tumorsphere formation, they slightly affected the expression of some of the
markers. It is possible that the mutants bind to the corresponding receptors but with much
lower affinity or non-specifically. In summary, this study demonstrated that cell adhesion
peptides could either increase or diminish CSC population in the inert 3D PEGDA
hydrogel cell culture system, as the mechanisms for CSC maintenance among these
peptides are different.
Using the 3D PEGDA matrix with a certain stiffness, we demonstrated that the cell
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adhesion CD44 binding peptide (CD44bp), RGD integrin binding peptide (Ibp), and
fibronectin-derived heparin binding peptide (FHbp) can be individually conjugated to the
inert PEGDA gel and their effect on the maintenance of breast cancer stem cells can be
investigated without the interference of other factors. The CD44bp and Ibp conjugated to
the inert gel completely abolished tumorsphere formation by the encapsulated 4T1 breast
cancer cells while FHbp enhanced tumorsphere formation compared to those without
peptide. The inert 3D hydrogel cell culturesystem provides a novel tool to investigate the
individual effect of factors in the microenvironment on maintenance of CSCs without the
interference of other factors.
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CHAPTER 4
CONCLUSION
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We introduced PEGDA hydrogels as an inert 3D microenvironment for studying the
individual effects of different parameters including ECM modulus on the survival and
maintenance of 4T1 murine breast CSCs to human cancer cell lines.
In particular, human breast, colon, gastric and bone cancer cell lines were also able to
sense and respond to change in elastic modulus through the change in the rate of
tumorigenicity. The optimized modulus for regulating tumorigenic capacity of cancer
cells was markedly different for different cell lines and it was found that at certain
modulus the proliferation capacity of cancer cells can be completely diminished.
Compared to conventional in vitro methods of culturing tumor spheroids in low-adhesion
plates, the PEGDA engineered matrix increased the tumorigenicity (density and number
of tumorspheres) and maintained CSCs properties for longer time periods. This could be
reasonably attributed to the suitable structure and mechanical properties of the matrix.
Consequently, the encapsulated cells mimic the actual tissue mechanobiology and
increase the possibility of EMT or similar biological events.
Our understanding of CSC maintenance mechanisms remains limited due to numerous
uncertainties in the transduction pathways of CSCs. Our developed synthetic microengineered matrix can be used as a tool to improve the cellular interaction level and
optimize temporal condition of CSCs microenvironment. This maintains stem cells
properties in vitro and makes it possible to study the regulatory effect of specific proteins
in biological pathways on CSC maintenance without interference of other factors.
By Using the 5kPa PEGDA matrix, we demonstrated that the cell adhesion CD44 binding
peptide (CD44bp), Integrin binding peptide (Ibps), and Heparin binding pepti de (Hbps)
can be individually conjugated to the inert PEGDA gel and their effect on the
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maintenance of breast cancer stem cells can be investigated without the interference of
other factors. The CD44bp and Ibps conjugated to the inert gel abolished tumorsphere
formation by the encapsulated 4T1 breast cancer cells while Hbps enhanced tumorsphere
formation compared to those without peptide. The inert 3D hydrogel cell culture system
provides a novel tool to investigate the individual effect of factors in the
microenvironment on maintenance of CSCs without the interference of other factors.
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